GITLAB INC., 10-K filed on 3/21/2025
Annual Report
v3.25.1
Cover - USD ($)
shares in Millions, $ in Billions
 12 Months Ended
Jan. 31, 2025
Mar. 07, 2025
Jul. 31, 2024
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 31, 2025    
Current Fiscal Year End Date --01-31    
Document Transition Report false    
Entity File Number 001-40895    
Entity Registrant Name GITLAB INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 47-1861035    
Title of 12(b) Security Class A common stock, par value $0.0000025per share    
Trading Symbol GTLB    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] true    
Document Financial Statement Restatement Recovery Analysis [Flag] true    
Entity Shell Company false    
Entity Public Float     $ 6.9
Documents Incorporated by Reference
Portions of the registrant’s Definitive Proxy Statement (“Proxy Statement”) relating to the 2025 Annual Meeting of Stockholders will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended January 31, 2025 and is incorporated by reference into Part III of this Report.
    
Entity Address, Address Line One 251 Little Falls Drive    
Entity Address, City or Town Wilmington    
Entity Address, State or Province DE    
Entity Address, Postal Zip Code 19808    
Entity Central Index Key 0001653482    
Current Fiscal Year Focus 2025    
Current Fiscal Period Focus FY    
Amendment Flag false    
Class A Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   144.6  
Class B Common Stock      
Document Information [Line Items]      
Entity Common Stock, Shares Outstanding   19.4  
v3.25.1
Audit Information
 12 Months Ended
Jan. 31, 2025
Audit Information [Abstract]  
Auditor Name KPMG LLP
Auditor Location Pittsburgh, Pennsylvania
Auditor Firm ID 185
v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents [1] $ 227,649 $ 287,996
Short-term investments [1] 764,728 748,289
Accounts receivable, net of allowance for doubtful accounts of $991 and $673 as of January 31, 2025 and January 31, 2024, respectively [1] 264,565 166,731
Deferred contract acquisition costs, current [1] 38,964 32,300
Prepaid expenses and other current assets [1] 40,411 49,143
Total current assets [1] 1,336,317 1,284,459
Property and equipment, net [1] 4,013 2,954
Operating lease right-of-use assets 381 [1] 405
Goodwill [1] 16,139 8,145
Intangible assets, net [1] 17,834 1,733
Deferred contract acquisition costs, non-current [1] 20,142 19,317
Other non-current assets [1] 4,437 4,390
TOTAL ASSETS [1] 1,399,263 1,321,403
CURRENT LIABILITIES:    
Accounts payable [1] 7,519 1,738
Accrued expenses and other current liabilities [1] 54,680 301,262
Accrued compensation and benefits [1] 40,233 35,809
Deferred revenue, current [1] 442,599 338,348
Total current liabilities [1] 545,031 677,157
Deferred revenue, non-current [1] 26,369 23,794
Other non-current liabilities [1] 6,557 14,060
TOTAL LIABILITIES [1] 577,957 715,011
Commitments and contingencies (Note 14) [1]
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.0000025 par value; 50,000 shares authorized as of January 31, 2025 and January 31, 2024; no shares issued and outstanding as of January 31, 2025 and January 31, 2024 [1] 0 0
Additional paid-in capital [1] 1,952,031 1,718,661
Accumulated deficit [1] (1,167,614) (1,161,288)
Accumulated other comprehensive income (loss) [1] (8,508) 2,398
Total GitLab stockholders’ equity [1] 775,909 559,771
Noncontrolling interests [1] 45,397 46,621
TOTAL STOCKHOLDERS’ EQUITY [1] 821,306 606,392
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY [1] 1,399,263 1,321,403
Class A Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, value, issued [1] 0 0
Class B Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, value, issued [1] $ 0 $ 0
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Allowance for doubtful accounts $ 991 $ 673
STOCKHOLDERS’ EQUITY:    
Preferred stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Assets of consolidated variable interest entity [1] $ 1,399,263 $ 1,321,403
Liabilities of consolidated variable interest entity [1] 577,957 715,011
Variable Interest Entity, Primary Beneficiary    
STOCKHOLDERS’ EQUITY:    
Assets of consolidated variable interest entity 46,498 51,168
Liabilities of consolidated variable interest entity $ 10,278 $ 10,079
Class A Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Common stock, shares authorized (in shares) 1,500,000,000 1,500,000,000
Common stock, shares issued (in shares) 144,444,000 114,670,000
Common stock, shares outstanding (in shares) 144,444,000 114,670,000
Class B Common Stock    
STOCKHOLDERS’ EQUITY:    
Common stock, par value (in USD per share) $ 0.0000025 $ 0.0000025
Common stock, shares authorized (in shares) 250,000,000 250,000,000
Common stock, shares issued (in shares) 19,469,000 42,887,000
Common stock, shares outstanding (in shares) 19,469,000 42,887,000
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Revenue $ 759,249 $ 579,906 $ 424,336
Cost of revenue 85,140 59,708 51,680
Gross profit 674,109 520,198 372,656
Operating expenses:      
Sales and marketing 384,295 356,393 309,992
Research and development 239,652 200,840 156,143
General and administrative 192,877 150,405 117,932
Total operating expenses 816,824 707,638 584,067
Loss from operations (142,715) (187,440) (211,411)
Interest income 47,735 39,114 14,496
Other income (expense), net 9,187 (12,241) 21,621
Loss before income taxes and loss from equity method investment (85,793) (160,567) (175,294)
Loss from equity method investment, net of tax 0 (3,824) (2,468)
Provision for (benefit from) income taxes (76,674) 265,145 4,030
Net loss (9,119) (429,536) (181,792)
Net loss attributable to noncontrolling interest (2,793) (3,859) (8,385)
Net loss attributable to GitLab $ (6,326) $ (425,677) $ (173,407)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in dollars per share) $ (0.04) $ (2.76) $ (1.17)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in dollars per share) $ (0.04) $ (2.76) $ (1.17)
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, basic (in shares) 160,580 154,283 148,407
Weighted-average shares used to compute net income (loss) per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares) 160,580 154,283 148,407
Subscription—self-managed and SaaS      
Revenue $ 675,179 $ 506,306 $ 369,349
Cost of revenue 64,916 45,486 40,841
License—self-managed and other      
Revenue 84,070 73,600 54,987
Cost of revenue $ 20,224 $ 14,222 $ 10,839
v3.25.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net loss $ (9,119) $ (429,536) $ (181,792)
Foreign currency translation adjustments (11,934) (3,937) (6,111)
Net change in unrealized gains (losses) on available-for-sale securities 371 5,000 (4,855)
Comprehensive loss including noncontrolling interest (20,682) (428,473) (192,758)
Net loss attributable to noncontrolling interest (2,793) (3,859) (8,385)
Foreign currency translation adjustments attributable to noncontrolling interest (657) (2,162) (2,300)
Comprehensive loss attributable to noncontrolling interest (3,450) (6,021) (10,685)
Comprehensive loss attributable to GitLab $ (17,232) $ (422,452) $ (182,073)
v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2022       27,141,000 119,747,000        
Stockholders' Equity, beginning balance at Jan. 31, 2022 $ 790,378     $ 0 $ 0 $ 1,320,479 $ (562,204) $ 7,839 $ 24,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       66,162,000 (66,162,000)        
Issuance of common stock related to vested exercised stock options (in shares)         2,940,000        
Issuance of common stock related to vested exercised stock options 24,846         24,846      
Issuance of common stock under employee stock purchase plan (in shares)       437,000          
Issuance of common stock under employee stock purchase plan 14,378         14,378      
Repurchases, net of early exercised stock options (in shares)         (36,000)        
Issuance of common stock related to RSUs vested (in shares)       915,000          
Vesting of early exercised stock options 4,706         4,706      
Stock-based compensation expense 122,567         114,811     7,756
Change in noncontrolling interest ownership 61,726         18,153     43,573
Deconsolidation of Arch, formerly Meltano (11,342)               (11,342)
Other comprehensive income (loss) (10,966)             (8,666) (2,300)
Net loss (181,792)           (173,407)   (8,385)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2023       94,655,000 56,489,000        
Stockholders' Equity, ending balance at Jan. 31, 2023 814,501     $ 0 $ 0 1,497,373 (735,611) (827) 53,566
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       16,995,000 (16,995,000)        
Issuance of common stock related to vested exercised stock options (in shares)         3,406,000        
Issuance of common stock related to vested exercised stock options 32,448         32,448      
Issuance of common stock under employee stock purchase plan (in shares)       417,000          
Issuance of common stock under employee stock purchase plan 12,933         12,933      
Repurchases, net of early exercised stock options (in shares)         (13,000)        
Issuance of common stock related to RSUs vested (in shares)       2,372,000          
Charitable donation of common stock (in shares)   231,408 231,000            
Charitable donation of common stock 10,700 $ 10,700       10,700      
Vesting of early exercised stock options 1,234         1,234      
Stock-based compensation expense 163,049         164,515     (1,466)
Change in noncontrolling interest ownership           (542)     542
Other comprehensive income (loss) 1,063             3,225 (2,162)
Net loss (429,536)           (425,677)   (3,859)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2024       114,670,000 42,887,000        
Stockholders' Equity, ending balance at Jan. 31, 2024 $ 606,392 [1]     $ 0 $ 0 1,718,661 (1,161,288) 2,398 46,621
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       25,933,000 (25,933,000)        
Issuance of common stock in connection with business combination, net (in shares)         27,000        
Issuance of common stock related to vested exercised stock options (in shares) 2,488,000       2,488,000        
Issuance of common stock related to vested exercised stock options $ 23,973         23,973      
Issuance of common stock under employee stock purchase plan (in shares)       420,000          
Issuance of common stock under employee stock purchase plan 13,556         13,556      
Issuance of common stock related to RSUs vested (in shares)       3,200,000          
Charitable donation of common stock (in shares)   221,195 221,000            
Charitable donation of common stock 11,827 $ 11,800       11,827      
Vesting of early exercised stock options 341         341      
Stock-based compensation expense 185,899         184,086     1,813
Change in noncontrolling interest ownership           (413)     413
Other comprehensive income (loss) (11,563)             (10,906) (657)
Net loss (9,119)           (6,326)   (2,793)
Stockholders' Equity, ending balance (in shares) at Jan. 31, 2025       144,444,000 19,469,000        
Stockholders' Equity, ending balance at Jan. 31, 2025 $ 821,306 [1]     $ 0 $ 0 $ 1,952,031 $ (1,167,614) $ (8,508) $ 45,397
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss, including amounts attributable to noncontrolling interest $ (9,119) $ (429,536) $ (181,792)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Stock-based compensation expense 185,899 163,049 122,567
Change in fair value of acquisition related contingent consideration 3,750 0 (1,722)
Charitable donation of common stock 11,827 10,700 0
Amortization of intangible assets 8,126 2,167 2,362
Depreciation expense 2,860 4,368 3,231
Amortization of deferred contract acquisition costs 49,714 43,463 44,958
Gain from deconsolidation of Arch, formerly Meltano 0 0 (17,798)
Loss from equity method investment 0 3,824 3,189
Impairment of equity method investment 0 8,858 0
Net amortization of premiums or discounts on short-term investments (16,746) (20,349) (6,077)
Unrealized foreign exchange loss (gain), net (9,526) 4,833 (3,964)
Other non-cash expense, net 930 1,330 1,156
Changes in assets and liabilities:      
Accounts receivable (99,649) (36,341) (54,169)
Prepaid expenses and other current assets 8,424 (23,688) (8,679)
Deferred contract acquisition costs (58,127) (53,100) (48,555)
Other non-current assets (183) (309) 3,012
Accounts payable 5,505 (3,443) 287
Accrued expenses and other current liabilities (253,369) 259,445 5,722
Accrued compensation and benefits 4,743 15,173 (11,693)
Deferred revenue 108,743 79,347 73,003
Other non-current liabilities (7,773) 5,249 (2,446)
Net cash provided by (used in) operating activities (63,971) 35,040 (77,408)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Purchases of short-term investments (707,698) (815,697) (821,622)
Proceeds from maturities of short-term investments 708,382 734,007 231,626
Purchases of property and equipment (3,765) (1,598) (6,070)
Deconsolidation of Arch, formerly Meltano 0 0 (9,620)
Payments for business combination, net of cash acquired (20,210) 0 0
Payments for asset acquisition (7,660) 0 0
Escrow payment related to business combination, after acquisition date 0 (2,500) 0
Other investing activities 457 (450) 0
Net cash used in investing activities (30,494) (86,238) (605,686)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases 23,964 32,302 24,515
Issuance of common stock under employee stock purchase plan 13,556 12,933 14,378
Contributions received from noncontrolling interests, net of issuance costs 0 0 61,726
Settlement of acquisition related contingent cash consideration (4,900) 0 (3,137)
Net cash provided by financing activities 32,620 45,235 97,482
Impact of foreign exchange on cash and cash equivalents 1,498 (3,943) (3,658)
Net decrease in cash and cash equivalents (60,347) (9,906) (589,270)
Cash and cash equivalents at beginning of period 287,996 297,902 887,172
Cash and cash equivalents at end of period 227,649 287,996 297,902
Supplemental disclosure of cash flow information:      
Cash paid for income taxes related to the bilateral advance pricing agreement 187,735 0 0
Other cash paid for income taxes 3,095 6,903 838
Supplemental disclosure of non-cash investing and financing activities:      
Acquisition measurement period adjustment 310 0 0
Vesting of early exercised stock options 341 1,234 4,706
Unpaid property and equipment in accounts payable 247 0 0
Reconciliation of cash, cash equivalents and restricted cash within the consolidated balance sheets to the amounts shown in the statements of cash flows above:      
Cash and cash equivalents 227,649 [1] 287,996 [1] 295,402
Restricted cash, included in prepaid expenses and other current assets 0 0 2,500
Cash and cash equivalents $ 227,649 $ 287,996 $ 297,902
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Organization and Description of Business
 12 Months Ended
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Description of Business
1. Organization and Description of Business
GitLab Inc. (the “Company”) began as an open source project in 2011 and was incorporated in Delaware on September 12, 2014. The Company operates on an all-remote model. The Company is a technology company and its primary offering is “GitLab”, a complete DevSecOps platform delivered as a single application. GitLab is used by a wide range of organizations. The Company also provides related training and professional services. GitLab is offered on both self-managed and software-as-a-service ("SaaS") models. The principal markets for GitLab are currently located in the United States, Europe, and Asia Pacific. The Company is focused on accelerating innovation and broadening the distribution of its platform to companies across the world to help them become better software-led businesses.
v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies
 12 Months Ended
Jan. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies
2. Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation
The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Fiscal Year
The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ended January 31, 2025 and 2024, respectively.
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, fair value of contingent consideration, taxation of intangible property in company formation, merger, or acquisition transactions, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation
The consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Foreign Currency
The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each foreign subsidiary and the variable interest entity in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary and the variable interest entity operate. Items included in the financial statements of such subsidiaries and the variable interest entity are measured using that functional currency.
Gains and losses that arise from foreign exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net on the consolidated statements of operations. For the years ended January 31, 2025, 2024 and 2023, the Company recognized foreign exchange gains (losses), net of $9.4 million, $(2.9) million and $5.1 million, respectively.
For subsidiaries and the variable interest entity where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate stockholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive income (loss) as a component of stockholders’ equity in the consolidated balance sheets. For the years ended January 31, 2025, 2024 and 2023, the Company recognized foreign translation adjustments of $(11.9) million, $(3.9) million and $(6.1) million, respectively.
Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents as of January 31, 2025 and 2024, consists of cash held in checking and savings accounts, investments in money market accounts and certain highly-liquid investments. The Company considers all highly-liquid investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents.
Restricted cash as of January 31, 2023, consists of a $2.5 million acquisition related security deposit withheld in an escrow for any potential post-closing indemnification claims. The Company fully paid this acquisition-related holdback during the year ended January 31, 2024. Refer to “Note 6. Acquisitions.”
Short-Term Investments - Marketable Securities
The Company classifies its marketable securities with stated maturities of three months and greater at the date of purchase as short-term investments due to its ability to use these securities to support the Company’s current operations.
As of January 31, 2025 and 2024, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. If the fair value of a security falls below its amortized cost, the carrying value is reduced to its fair value if management intends to sell or it is more likely than not that it will be required to sell before recovery of the amortized cost basis. If neither of these conditions are satisfied, impairment is assessed for credit losses by comparing the present value of expected cash flows with the amortized cost basis, and an allowance for credit losses is recorded for the excess of amortized cost over expected cash flows. Impairment losses not attributable to credit losses are reported as a separate component of other comprehensive loss, net of tax.
The cost of securities sold is based on the specific-identification method. Unrealized gains and losses are reported as a separate component of accumulated other comprehensive income (loss). Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the consolidated statements of operations. Interest on securities classified as available-for-sale is included within interest income on our consolidated statements of operations.
Available-for-sale securities are recorded at fair value each reporting period and are adjusted for the amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income of the consolidated statements of operations.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable, which represent trade receivables from the Company’s customers, are recorded at the invoiced amount and do not bear interest. The Company extends credit of typically 30 to 60 days to its customers in the normal course of business and does not require collateral from its customers. The allowance for doubtful accounts is the Company’s best estimate of the amount of expected credit losses in existing accounts receivable.
As of January 31, 2025 and 2024, the allowance for doubtful accounts was $1.0 million and $0.7 million, respectively. Accounts receivable deemed uncollectible are written off against the allowance when identified.
Concentration of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these
balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary.
The Company uses various distribution channels. As of January 31, 2025, two of these channel partners represented 11% and 12% of the accounts receivable balance, respectively, while as of January 31, 2024, two of these channel partners represented 12% and 13% of the accounts receivable balance. There were no individual customers whose balance represented more than 10% of accounts receivable as of January 31, 2025 and 2024.
There were no individual customers whose revenue represented more than 10% of total revenue during the years ended January 31, 2025, 2024 and 2023.
Fair Value of Financial Instruments
We define fair value as the price that would be received from selling an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for cash equivalents, restricted cash, short-term investments, accounts receivable, accounts payable and accrued liabilities due to their short-term nature. The Company also recorded acquisition related contingent considerations at fair value, as further discussed in “Note 4. Cash Equivalents and Short-Term Investments.”
The Company measures assets and liabilities at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value:
Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.
Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability.
Revenue Recognition
The Company generates revenue primarily from offering self-managed (on-premise) and SaaS subscriptions. Revenue is also generated from professional services, including consulting and training.
In accordance with ASC 606, revenue is recognized when a customer obtains control of the promised products and services. The amount of revenue recognized reflects the consideration that the Company expects to be entitled to receive in exchange for these products and services. To achieve the core principle of this standard, the Company applies the following five-step model as a framework:
1)Identify the contract with a customer. We consider the terms and conditions of our arrangements with customers to identify contracts under ASC 606. We consider that we have a contract with a customer when the contract is approved, we can identify each party's rights regarding the products and services to be transferred, we can identify the payment terms for the products and
services, we have determined the customer has the ability and intent to pay, and the contract has commercial substance. We apply judgment in determining the customer's ability and intent to pay, which is based upon factors including the customer's historical payment experience or, for new customers, credit and financial information pertaining to the customers. At contract inception, we also evaluate whether two or more contracts should be combined and accounted for as a single contract. Further, contract modifications generally qualify as a separate contract.
The typical term of a subscription contract for a self-managed or SaaS offering is one to three years. Our contracts are non-cancelable over the contract term and we act as principal in all our customer contracts. Customers have the right to terminate their contracts generally only if we breach the contract and we fail to remedy the breach in accordance with the contractual terms.
2)Identify the performance obligations in the contract. Performance obligations in our contracts are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.
Our self-managed subscriptions include two performance obligations: (i) to provide access to proprietary features in our software, and (ii) to provide support and maintenance (including the combined obligation to provide software updates on a when-and-if-available basis).
Our SaaS products provide access to hosted software as well as support, which is evaluated to be a single performance obligation.
Services-related performance obligations relate to the provision of consulting and training services. These services are distinct from subscriptions and do not result in significant customization of the software.
Some of our customers have the option to purchase additional licenses or renew at a stated price. These options are evaluated on a case-by-case basis but generally do not provide a material right as they are either at the same price as the existing licenses or are within our range of standalone selling price (“SSP”) and, as such, would not result in a separate performance obligation. Where material rights are identified in our contracts, they are treated as separate performance obligations.
3)Determine the transaction price. We determine transaction price based on the consideration to which we expect to be entitled in exchange for transferring products and services to the customer.
Our contracts are non-refundable and non-cancellable. We do not offer refunds, rebates, or credits to our customers in the normal course of business.
For contracts with a one year term, we applied a practical expedient available under ASC 606 and therefore do not make an evaluation for the existence of a significant financing component. In these contracts, at contract inception, the period between when we expect to transfer a promised product or service to the customer and when the customer pays for that product or service will be one year or less. For contracts with terms of more than a year, we have applied judgment in determining that advance payments in such contracts are not collected with the primary intention of availing finance and therefore, do not represent a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). We do not offer the right of refund in our contracts.
4)Allocate the transaction price to the performance obligations in the contract. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, we allocate the transaction price for each contract to each performance obligation based on the relative SSP
for each performance obligation. We use judgment in determining the SSP for our products and services. We typically assess the SSP for our products and services on an annual basis or when facts and circumstances change. To determine SSP, we maximize the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, we utilize available information that may include other observable inputs or use the expected cost-plus margin approach to estimate the price we would charge if the products and services were sold separately. The expected cost-plus margin approach is currently used to determine SSP for each distinct performance obligation for self-managed subscriptions.
We have concluded that (i) the right to use the software and (ii) the right to receive technical support and software fixes and updates are two distinct performance obligations in our self-managed subscriptions. Since neither of these performance obligations are sold on a standalone basis, we estimate SSP for each performance obligation using a model based on the “expected cost-plus margin” approach and update the model on an annual basis or when facts and circumstances change. This model uses observable data points to develop the main inputs and assumptions, which include the estimated historical costs to develop the paid features in the software license and the estimated future costs to provide post-contract customer support.
5)Revenue is recognized when or as we satisfy a performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised products and services to a customer. We recognize revenue when we transfer control of the products and services to our customers for an amount that reflects the consideration that we expect to receive in exchange for those products and services. All revenue is generated from contracts with customers.
Subscription - self-managed and SaaS
Subscription - self-managed
The Company's self-managed subscriptions include support, maintenance, upgrades, and updates on a when-and-if-available basis. Revenue for self-managed subscriptions is recognized ratably over the contract period based on the stand-ready nature of subscription elements.
The Company offers two tiers of paid subscriptions as part of the self-managed model: Premium and Ultimate.
The typical term of a subscription contract for self-managed offerings is one to three years.
SaaS
We also offer two tiers of paid SaaS subscriptions: Premium and Ultimate. These subscriptions provide access to our latest managed version of our product hosted in a public or private cloud based on the customer’s preference. Revenue from our SaaS products (Subscription revenue - SaaS) is recognized ratably over the contract period when the performance obligation is satisfied.
The typical term of a subscription contract for SaaS offering is one to three years.
License - self-managed and other
The license component of our self-managed subscriptions reflects the revenue recognized by providing customers with rights to use proprietary software features.
Other revenue consists of professional services revenue which is derived from fixed fee and time and materials offerings, subject to customer acceptance for certain fixed fee offerings. Uncertainty exists about customer acceptance and therefore, control is presumed to transfer upon confirmation from the customer, as defined in each professional services contract. Accordingly, revenue is recognized upon
satisfaction of all requirements per the applicable contract. Revenue from professional services provided on a time and material basis is recognized over the period services are delivered.
The Company presents financial information about disaggregation of revenue in “Note 3. Revenues” of the consolidated financial statements.
Deferred Revenue and Contract Assets
Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. The portion of deferred revenue that the Company will recognize during the twelve-month period from the balance sheet date is recorded within current liabilities and the remaining portion is recorded as long-term.
The Company receives payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Customers are generally billed in advance, including some multi-year contracts, but the majority of customers in multi-year contracts specifically request to pay annually in advance. Where the value of revenue recognized exceeds the value of amounts invoiced for a contract at the end of a reporting period, the excess is reclassified from deferred revenue to contract assets until invoiced. Contract assets are included in prepaid expenses and other current assets on the consolidated balance sheets.
During the years ended January 31, 2025, 2024 and 2023, $331.8 million, $217.0 million and $145.9 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the reporting periods presented.
Remaining Performance Obligations
As of January 31, 2025, the aggregate transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $945.0 million. Of this amount, the Company expects to recognize approximately 61% over the next 12 months and 87% over the next 24 months.
Deferred Contract Acquisition Costs
Sales commissions and bonuses that are recoverable and incremental costs of obtaining contracts with customers are capitalized.
Commissions and bonuses paid upon the acquisition of an initial contract are amortized over an estimated period of benefit which has been determined generally to be 3 years based on historical analysis of average customer life and useful life of our product offerings. Commissions paid for subsequent renewals are amortized over the renewal term. Amortization is recognized on a straight-line basis and included in sales and marketing expenses in the consolidated statements of operations. However, costs for commissions that are incremental to obtain a self-managed license contract are expensed immediately. The Company periodically reviews these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. The Company did not recognize any impairment of deferred contract acquisition costs during the periods presented.
Cost of Revenue
Cost of revenue for self-managed and SaaS subscriptions consists primarily of allocated cloud-hosting costs paid to third party service providers, personnel-related costs associated with our customer
support personnel, including contractors, third-party payment processing fees, and allocated overhead. Personnel-related expenses consist of salaries, benefits, bonuses, and stock-based compensation.
Cost of self-managed license and other revenue consists primarily of contractor and personnel-related costs, including stock-based compensation expenses, associated with the professional services team and customer support team, and allocated overhead.
Research and Development
Costs related to research and development of the Company’s software offerings are expensed as incurred. These costs consist primarily of compensation paid to the Company's research and development personnel, including contractors.
The Company’s internal customer software development process follows an iterative process that results in more frequent software releases than do traditional sequential or waterfall development methodologies and also results in internal validation of the software releases very shortly before they are made available to customers. Therefore, to date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility through internal validation of the software releases. As such, all related software development costs are expensed as incurred and included in research and development expenses in the consolidated statements of operations. To date, software development for internal use has been immaterial and no such costs have been capitalized.
Advertising Costs
Advertising costs are expensed as incurred and are included within sales and marketing expenses in the consolidated statements of operations. These include costs incurred on public relations, website design, advertising, field marketing, and market research services. The Company incurred advertising costs of $34.5 million, $32.5 million and $27.3 million during the years ended January 31, 2025, 2024 and 2023, respectively.
Loss Contingencies
If an exposure to any potential claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company records a liability for the estimated loss. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. If applicable, the Company records receivables for probable insurance or other third-party recoveries. Due to uncertainties related to these matters, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise its estimates. These revisions in the estimates of the potential liabilities could have a material impact on the Company’s results of operations and financial position. Legal fees and other costs associated with such actions are expensed as incurred.
Income Taxes
The Company is subject to income taxes in the United States and several foreign jurisdictions. The Company records a provision for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and the tax basis of assets and liabilities, as well as for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled.
Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. Management applies significant judgment in assessing the positive and negative evidence available in the determination of the amount of deferred tax assets that
were more likely than not to be realized in the future. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences, and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed.
Compliance with income tax regulations requires the Company to take certain tax positions. In assessing the exposure associated with various filing positions, the Company determines whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of the available evidence indicates that it is more likely than not that the position will be sustained upon tax authority examination, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than fifty percent likely of being realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits, if any, are included within the provision for income taxes in the consolidated statement of operations.
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive loss includes net loss and changes in stockholders’ equity that are excluded from net loss due to changes in the Company’s cumulative foreign currency translation account and unrealized gains or losses on short-term investments.
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share is based on the weighted-average effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted-average shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. We exclude equity instruments from the calculation of diluted loss per share if the effect of including such instruments is anti-dilutive. Since we are in a net loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potentially dilutive securities outstanding would have been anti-dilutive.
Stock-Based Compensation
The Company has granted equity classified stock-based awards to team members, members of its board of directors, and non-employee advisors. The majority of the Company's stock-based awards have been granted to team members and the service-based vesting condition for the majority of these awards is satisfied over four years.
The cost of stock-based awards granted to team members is measured at the grant date, based on the fair value of the award, and is generally recognized as expense on a straight-line basis over the requisite service period. Forfeitures are recorded as they occur. The Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options.
In May 2021, the Company granted 3 million shares of restricted stock units (“RSUs”) tied to our Class B common stock to Mr. Sijbrandij, our Co-founder and former CEO. The RSUs contain a service condition and a performance condition based on the achievement of eight separate stock price hurdles/tranches ranging from $95 to $500 per share. The fair value of the RSUs was determined utilizing a
Monte Carlo valuation model. We recognize total stock-based compensation expense over the derived service period of each tranche using the accelerated attribution method, regardless of whether the stock price hurdles are achieved. The RSUs were forfeited during the year ended January 31, 2025. Refer to “Note 9. Equity” for further discussion.
In September 2021, our board of directors and our stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of our Class A common stock with accumulated payroll deductions. We recognize stock-based expenses related to the shares to be issued under the ESPP on a straight-line basis over the offering period, using the Black-Scholes option-pricing model. We have been determining the volatility input based on the historical volatility of our peer group until such time as we established a 2-year public trading history of our own stock price. For the new offering period starting December 2023, we transitioned to using an average blend of historical volatility of our peer group and volatility of our own stock price when determining the volatility input.
Since fiscal year 2023, JiHu has maintained an employee stock option plan ("JiHu 2022 ESOP") for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan ("JiHu 2024 ESOP") for its employees in order to grant additional shares. The fair value of Restricted Stock Awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP ("JiHu ESOPs"). The Company considers the RSAs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such awards (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest.
In June 2022, the Company granted 0.4 million performance stock units (“2022 PSUs”) to senior members of its management team and in December 2024, the Company granted 0.3 million performance stock units (“2024 PSUs”) to its new Chief Executive Officer (“CEO”). The 2022 and 2024 PSUs are subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. The fair value of 2022 and 2024 PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to awards expected to vest are recognized on a graded-vesting method over the requisite service periods. The estimate of awards expected to vest is reassessed by management at each reporting period.
Segment Reporting
The Company derives revenue globally and manages its business activities on a consolidated basis. The Company’s primary offering is GitLab, a complete DevSecOps platform delivered as a single application which is offered on both self-managed and SaaS models.
The Company operates its business as one operating and reportable segment as the Company’s chief operating decision maker (“CODM”), the Company’s CEO, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance.
The Company’s CODM primarily uses consolidated net loss as the measure of profit or loss to facilitate analysis of the Company’s financial trends, and for internal planning and forecasting purposes. Consolidated expense information is included on the consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheet as total assets.
The Company presents financial information about geographical mix of revenue in “Note 3. Revenues” of the consolidated financial statements.
Business Combination
We include the results of operations of the businesses that we acquire beginning from the respective dates of acquisition. We allocate the fair value of the purchase price of our acquisitions to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill.
We amortize our acquired intangible assets with definite lives on a straight-line basis over a period of three years.
The liabilities for any contingent consideration are established at the time of the acquisition and will be evaluated at each reporting date. Any change in the fair value adjustment is recorded in general and administrative expenses.
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. The Company depreciates leasehold improvements over the shorter of the remaining lease term or estimated useful life of five years, and computers over two years.
Leases
The Company determines whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether the Company controls the use of the identified asset throughout the period of use. At the lease commencement date, the Company determines the lease classification between finance and operating and recognizes a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents the Company’s right to use an underlying asset and a lease liability represents the Company’s obligation to make payments during the lease term. The Company has operating leases for office premises leased by JiHu, as well as for an immaterial short-term sales office in India. The Company accounts for lease components and non-lease components separately. The Company does not recognize operating lease right-of-use assets and operating lease liabilities that arise from short-term leases (i.e., leases with a term of 12 months or less).
The lease liability is initially measured as the present value of the remaining lease payments over the lease term. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate used to determine the present value is the Company’s incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. The Company estimates its incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments adjusted for prepaid lease payments to lessors.
Lease expense is recognized on a straight-line basis over the lease term.
Impairment of Long-lived Assets
We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset (including an intangible asset) may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future undiscounted cash flow the asset is expected to generate. We measure recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If a long-lived asset (including an intangible asset) is considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value. We have made no material adjustments to our long-lived assets (including intangible assets) in any of the years presented.
We test our goodwill for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. Based on an analysis of qualitative and quantitative factors, including our market capitalization, we determined there to be no impairment of goodwill in any of the periods presented.
Equity Method Investment
The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in a former subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our consolidated statements of operations. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Refer to “Note 11. Joint Venture and Equity Method Investment” for more information.
Revision of Previously Issued Consolidated Financial Statements
During the quarter ended January 31, 2025, the Company identified errors related to the understatement of certain tax liabilities associated with the formation of our joint venture, JiHu in February 2021. The Company concluded that the impact of the errors on previously issued consolidated financial statements as of and for the annual periods ended January 31, 2024 and January 31, 2023 were immaterial. However, the Company has revised the prior-period consolidated financial statements to correct these errors.
The following tables summarize the revisions of previously-issued consolidated financial statements (in thousands):
Consolidated Balance Sheet
January 31, 2024
As Previously ReportedAdjustmentAs Revised
ASSETS
CURRENT ASSETS:
Prepaid expenses and other current assets$45,601 $3,542 $49,143 
Total current assets1,280,917 3,542 1,284,459 
TOTAL ASSETS$1,317,861 $3,542 $1,321,403 
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accrued expenses and other current liabilities$286,178 $15,084 $301,262 
Total current liabilities662,073 15,084 677,157 
TOTAL LIABILITIES699,927 15,084 715,011 
STOCKHOLDERS’ EQUITY:
Accumulated deficit(1,149,822)(11,466)(1,161,288)
Accumulated other comprehensive income2,335 63 2,398 
Total GitLab stockholders’ equity571,174 (11,403)559,771 
Noncontrolling interests46,760 (139)46,621 
TOTAL STOCKHOLDERS’ EQUITY617,934 (11,542)606,392 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$1,317,861 $3,542 $1,321,403 
Consolidated Statements of Operations and Consolidated Statements of Comprehensive Loss
Year Ended January 31, 2024
As Previously ReportedAdjustmentAs Revised
Other expense, net$(11,826)$(415)$(12,241)
Loss before income taxes and loss from equity method investment
(160,152)(415)(160,567)
Provision for income taxes264,057 1,088 265,145 
Net loss$(428,033)$(1,503)$(429,536)
Net loss attributable to GitLab(424,174)(1,503)(425,677)
Foreign currency translation adjustments$(4,122)$185 $(3,937)
Comprehensive loss attributable to GitLab$(421,134)$(1,318)$(422,452)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(2.75)$(0.01)$(2.76)

Year Ended January 31, 2023
As Previously ReportedAdjustmentAs Revised
Other income, net$21,585 $36 $21,621 
Loss before income taxes and loss from equity method investment
(175,330)36 (175,294)
Provision for income taxes2,898 1,132 4,030 
Net loss$(180,696)$(1,096)$(181,792)
Net loss attributable to GitLab(172,311)(1,096)(173,407)
Foreign currency translation adjustments$(5,874)$(237)$(6,111)
Comprehensive loss attributable to GitLab$(180,740)$(1,333)$(182,073)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(1.16)$(0.01)$(1.17)

Impacted financial statement line items appearing in the Company’s consolidated statements of stockholders’ equity have also been revised accordingly. Cash flows from operating, investing and financing activities for the above periods were not impacted by this immaterial correction of an error. However, net loss was revised, as shown above, with an offset to the prepaid expenses and other current assets and accrued expenses and other current liabilities captions within operating activities on the consolidated statements of cash flows. Accordingly, a revision table for the consolidated statement of cash flows is not included.
Recently Adopted Accounting Standards
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which requires public entities to disclose expanded information about their reportable segment(s)’ significant expenses and other segment items on an interim and annual basis. The Company adopted the ASU retrospectively on January 1, 2024 and the adoption did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Standards Not Yet Adopted
In December 2023, the FASB issued ASU 2023-09, Income Taxes ("Topic 740"): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires public entities to disclose specific tax rate reconciliation categories, as well as income taxes paid disaggregated by jurisdiction, amongst other disclosure enhancements. The ASU is effective for annual periods beginning after December 15, 2024,
with early adoption permitted. The Company has not early adopted ASU 2023-09 and is currently evaluating the impact on the consolidated financial disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement: Reporting Comprehensive Income - Expense Disaggregation Disclosures (“Subtopic 220-40”): Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expenses. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company has not early adopted ASU 2024-03 and is currently evaluating the impact on the consolidated financial disclosures.
v3.25.1
Revenues
 12 Months Ended
Jan. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenues
3. Revenues
Disaggregation of Revenue
The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages):
Fiscal Year Ended January 31,
202520242023
Subscription—self-managed and SaaS$675,179 89 %$506,306 87 %$369,349 87 %
Subscription—self-managed458,883 61 355,707 61 275,275 65 
SaaS216,296 28 150,599 26 94,074 22 
License—self-managed and other$84,070 11 %$73,600 13 %$54,987 13 %
License—self-managed68,366 9 63,110 11 46,046 11 
Professional services and other15,704 2 10,490 2 8,941 2 
Total revenue$759,249 100 %$579,906 100 %$424,336 100 %
Total Revenue by Geographic Location
The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands):
Fiscal Year Ended January 31,
202520242023
United States$618,658 $473,021 $352,975 
Europe122,651 93,292 61,820 
Asia Pacific17,940 13,593 9,541 
Total revenue$759,249 $579,906 $424,336 
During the years ended January 31, 2025, 2024 and 2023, the United States accounted for 82%, 82% and 83% of total revenue for each period presented. No other individual country exceeded 10% of total revenue for any of the periods presented.
v3.25.1
Cash Equivalents and Short-Term Investments
 12 Months Ended
Jan. 31, 2025
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Short-Term Investments
4. Cash Equivalents and Short-Term Investments
The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands):
As of January 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$97,093 $— $— $97,093 
Level 2:
Cash equivalents
    U.S. Treasury securities36,429 8 — 36,437 
Total cash equivalents (1)
133,522 8 — 133,530 
Short-term investments
    Commercial paper19,400 4 (11)19,393 
    Corporate debt securities220,326 327 (148)220,505 
    U.S. Agency securities61,020 20 (65)60,975 
 U.S. Treasury securities463,474 521 (140)463,855 
Total short-term investments764,220 872 (364)764,728 
Level 2 total800,649 880 (364)801,165 
Total cash equivalents and short-term investments$897,742 $880 $(364)$898,258 
(1) Included in “cash and cash equivalents” in our consolidated balance sheet as of January 31, 2025, in addition to cash of $94.1 million.
As of January 31, 2024
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$187,175 $— $— $187,175 
Level 2:
Cash equivalents
    U.S. Treasury securities15,909 — (2)15,907 
    Commercial paper3,962 — (1)3,961 
Total cash equivalents (1)
207,046 — (3)207,043 
Short-term investments
    Commercial paper23,229 14 (1)23,242 
    Corporate debt securities231,219 740 (250)231,709 
    U.S. Agency securities56,324 29 (136)56,217 
    U.S. Treasury securities437,369 141 (389)437,121 
Total short-term investments748,141 924 (776)748,289 
Level 2 total768,012 924 (779)768,157 
Total cash equivalents and short-term investments$955,187 $924 $(779)$955,332 
(1) Included in “cash and cash equivalents” in our consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million.
The fair value of the Company’s Level 1 financial instruments, such as money market funds which are traded in active markets, is based on quoted market prices for identical instruments. The fair value of the Company’s Level 2 financial instruments such as commercial paper, corporate debt and U.S. government securities are obtained from an independent pricing service, which may use inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. The Company’s marketable securities are held by custodians who obtain investment prices from a third-party pricing provider that incorporates standard inputs in various asset price models.
The Company uses the specific-identification method to determine any realized gains or losses from the sale of the Company’s short-term investments classified as available-for-sale. For the periods presented, the Company did not have any material realized gains or losses as a result of maturities or sales of short-term investments.
During the years ended January 31, 2025, 2024 and 2023, the Company recorded $47.7 million, $39.1 million and $14.5 million of interest income on cash and cash equivalents and short-term investments, respectively, which includes $16.7 million, $20.3 million and $6.1 million of net amortization of premiums or discounts on short-term investments during the years ended January 31, 2025, 2024 and 2023, respectively.
The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands):
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2025
    U.S. Agency securities$48,445 $(65)$— $— $48,445 $(65)
    Commercial paper13,430 (11)— — 13,430 (11)
    Corporate debt securities72,022 (146)5,988 (2)78,010 (148)
    U.S. Treasury securities100,921 (140)— — 100,921 (140)
Total cash equivalents and short-term investments$234,818 $(362)$5,988 $(2)$240,806 $(364)
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2024
    U.S. Agency securities$35,979 $(53)$11,386 $(83)$47,365 $(136)
    Commercial paper15,462 (2)— — 15,462 (2)
    Corporate debt securities85,998 (192)15,485 (58)101,483 (250)
    U.S. Treasury securities139,567 (192)41,193 (199)180,760 (391)
Total cash equivalents and short-term investments$277,006 $(439)$68,064 $(340)$345,070 $(779)
The following table classifies the Company’s short-term investments by contractual maturities (in thousands):
January 31, 2025January 31, 2024
Amortized costFair ValueAmortized costFair Value
Due within 1 year$590,193 $590,832 $619,286 $618,765 
Due between 1 year to 2 years174,027 173,896 128,855 129,524 
Total$764,220 $764,728 $748,141 $748,289 
All available-for-sale securities have been classified as current, based on management’s ability to use the funds in current operations.
Liabilities are measured at fair value on a recurring basis. The Company had contingent cash consideration from a business combination which was determined based upon the satisfaction of certain defined operational milestones and was remeasured at fair value at each reporting period through earnings. As the fair value is based on unobservable inputs, the liability is included in Level 3 of the fair value measurement hierarchy.
During the years ended January 31, 2025, 2024 and 2023, the Company reassessed the fair value of outstanding operational milestones and recorded a $3.8 million loss in fair value, zero and a $1.7 million gain in fair value, respectively. The change in fair value was included in general and administrative expenses in the consolidated statement of operations for the years ended January 31, 2025, 2024 and 2023, respectively.
In October 2024, the remaining operational milestones were achieved, and the Company paid $7.5 million of contingent cash consideration during the year ended January 31, 2025. The Company had zero and $3.6 million of Level 3 contingent consideration payable as of January 31, 2025 and January 31, 2024, respectively.
Interest accretion expense was $0.1 million, $0.2 million and $0.3 million for the years ended January 31, 2025, 2024 and 2023, respectively.
v3.25.1
Supplemental Financial Statement Information
 12 Months Ended
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Financial Statement Information
5. Supplemental Financial Statement Information
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
January 31, 2025January 31, 2024
Prepaid software subscriptions$10,769 $12,835 
Prepaid income taxes 6,302 7,891 
Interest receivable5,893 4,159 
Indirect tax credit receivable (1)
3,698 3,663 
Prepaid insurance2,945 2,718 
Revenue contract asset2,432 1,910 
Other prepaid expenses2,199 1,776 
Vendor receivable1,951 2,000 
Prepaid expenses for the Company’s events1,950 9,245 
Prepaid advertising costs689 1,621 
Security and other deposits264 371 
Other current assets1,319 954 
Total prepaid expenses and other current assets$40,411 $49,143 
(1) The Company revised prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Property and Equipment, Net
Property and equipment, net of the following (in thousands):
January 31, 2025January 31, 2024
Computer and office equipment $7,012 $9,182 
Leasehold improvements78 1,154 
7,090 10,336 
Less: Accumulated depreciation (1)
(3,077)(7,382)
Total property and equipment, net (1)
$4,013 $2,954 
(1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. As of January 31, 2025 and January 31, 2024, the Company also wrote off $7.2 million and $1.1 million of fully depreciated assets as they were no longer in use, respectively.
Depreciation expense of property and equipment was $2.9 million, $4.4 million and $3.2 million for the years ended January 31, 2025, 2024 and 2023, respectively.
Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
January 31, 2025January 31, 2024
Security and other deposits$3,924 $3,495 
Deferred software implementation costs143 336 
Other non-current assets370 559 
Total other non-current assets$4,437 $4,390 
Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
January 31, 2025January 31, 2024
Indirect taxes payable (1)
$18,779 $9,971 
Accrued expenses13,292 11,499 
Income taxes payable (1)
13,111 11,253 
Customer refunds payable6,268 3,019 
ESPP employee contributions2,955 2,827 
Operating lease liabilities, current275 410 
Income tax liability related to BAPA (2)
— 258,675 
Acquisition related liabilities (3)
— 3,608 
Total accrued expenses and other current liabilities$54,680 $301,262 
(1) The Company has revised prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
(2) Refer to “Note 12. Income Taxes”.
(3) Refer to “Note 4. Cash Equivalents and Short-Term Investments”.
Accrued Compensation and Benefits
Accrued compensation and benefits consisted of the following (in thousands):
January 31, 2025January 31, 2024
Accrued commissions$16,538 $12,734 
Other accrued team member related payables15,564 13,581 
Payroll taxes payable 8,131 9,306 
Restructuring accrual and related charges (1)
— 188 
Total accrued compensation and benefits$40,233 $35,809 
(1) Refer to “Note 10. Restructuring and Other Related Charges”.
Other Non-Current Liabilities
Other non-current liabilities consisted of the following (in thousands):
January 31, 2025January 31, 2024
Long term taxes payable$4,888 $771 
Provision towards labor matters (1)
1,380 2,197 
Operating lease liabilities, non-current117 — 
Early exercised options liability70 420 
Deferred tax liabilities, net44 10,560 
Other non-current liabilities 58 112 
Total other non-current liabilities$6,557 $14,060 
(1) Refer to “Note 14. Commitments and Contingencies”.
Other Income (Expense), Net
Other income (expense), net consisted of the following (in thousands):
Fiscal Year Ended January 31,
202520242023
Gain from deconsolidation of Arch, formerly Meltano$— $— $17,798 
Impairment loss of equity method investment in Arch, formerly Meltano— (8,858)— 
Foreign exchange gains (losses), net9,416 (2,871)5,131 
Other expense, net(229)(512)(1,308)
Total other income (expense), net$9,187 $(12,241)$21,621 
v3.25.1
Acquisitions
 12 Months Ended
Jan. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions
6. Acquisitions
Opstrace
On December 3, 2021, the Company completed the acquisition of Opstrace, Inc., a technology company based in San Francisco, California.
The transaction was accounted for as a business combination. The acquisition date fair value of the consideration transferred was $13.5 million, which included contingent cash consideration.
As of January 31, 2023, the Company held $2.5 million in an escrow as partial security for post-closing indemnification claims made within 18 months of the closing date. The Company fully paid out this acquisition-related holdback during the year ended January 31, 2024.
Rezilion
On May 23, 2024 (the “Asset Acquisition Date”), the Company completed its acquisition of certain assets, primarily software intellectual property, of Rezilion Inc. and its subsidiary, Rezilion Ltd. (collectively, “Rezilion”) for approximately $7.3 million in cash.
The Rezilion transaction was accounted for as an asset acquisition because substantially all of the fair value of gross assets acquired were concentrated in the developed intellectual property. Acquisition-related direct transaction costs were capitalized as a component of the cost of the assets acquired.
On the Asset Acquisition Date, the fair value of the developed technology was $7.7 million including $0.4 million of acquisition-related direct costs. The developed technology acquired has an estimated useful life of three years.
Oxeye
On March 20, 2024 (the “Acquisition Date”), the Company completed the acquisition of Oxeye Security Limited (“Oxeye”), a cloud-native application security and risk management solution company based in Israel. The Company believes this acquisition will allow the Company to strengthen its product offerings.
The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands):
Closing cash consideration$16,737 
Cash held in escrow3,593 
Total consideration$20,330 
Total consideration includes $3.6 million deposited in an escrow account as partial security for post-closing indemnification claims made within 15 months of the Acquisition Date. As the Company is not the legal owner of the escrow account, it is not recorded on the consolidated balance sheet as of January 31, 2025.
As part of the acquisition, there was also a holdback in the amount of $3.2 million to be paid to the two co-founders (the “founder holdback”) in three equal tranches of 33.3%. The first such payment will be paid if certain milestones are achieved on or before the first anniversary of the closing date, provided such founder is employed by the Company upon completion of the milestones. The second and third tranches will be paid provided such founder is employed by the Company on the second and third anniversaries of the closing dates, respectively. As the founder holdback arrangement represents compensation for post-combination services, the Company has excluded the entire $3.2 million from the purchase price to be allocated, and will recognize the amount as expense over the period of services rendered after factoring in the likelihood of achieving the milestones in the first year.
During the year ended January 31, 2025, the milestones attached to the first payment tranche were achieved and $1.1 million was paid out to the two co-founders. The Company recorded $1.1 million of the founder holdback in general and administrative expenses in its consolidated statement of operations for the year ended January 31, 2025.
Acquisition related transaction costs were $1.2 million for the year ended January 31, 2025, and were recorded by the Company in general and administrative expenses in its consolidated statement of operations.
The Company recorded the assets acquired and liabilities assumed at their estimated fair values, with the difference between the fair value of the net assets acquired and the purchase consideration reflected in goodwill. The total purchase price of $20.3 million was allocated using information available to the Company at the time of acquisition. The Company may continue to adjust the preliminary purchase price allocation after obtaining more information regarding asset valuations, liabilities assumed, tax-related items and revisions of preliminary estimates.
During the year ended January 31, 2025, The Company recorded an acquisition measurement period adjustment of $0.3 million to reflect adjustments to certain deferred tax assets resulting from the filing of income tax returns for the periods prior to acquisition date. These purchase price allocation adjustments resulted in a $0.3 million decrease to goodwill and a corresponding increase to the deferred tax liability
during the one year measurement period. They do not impact net income or the earnings per share in this period.
The following table reflects the fair values of assets acquired and liabilities assumed at the acquisition date (in thousands):
Cash and cash equivalents$120 
Developed technology16,276 
Goodwill8,055 
Prepaid expenses and other current assets121 
Accrued expenses and payroll(3,582)
Deferred tax liability (660)
Net assets acquired$20,330 
As of the Acquisition Date, developed technology of the acquired business had an estimated useful life of three years. The fair value of the developed technology intangible asset was estimated using the replacement cost method, which utilizes assumptions for the cost to replace it, such as time and resources required, as well as a theoretical profit margin and opportunity costs. The goodwill is primarily attributed to the synergies expected to be realized following the acquisition. The goodwill is not deductible for Israeli income tax purposes.
Results of operations of the business acquired have been included in the Company’s consolidated financial statements subsequent to the date of acquisition. The revenue and net income (loss) earned by the business acquired following the acquisition are not material to the Company’s consolidated results of operations; and accordingly, pro forma financial statements have not been presented.
v3.25.1
Goodwill and Intangible Assets, Net
 12 Months Ended
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
7. Goodwill and Intangible Assets, Net
Goodwill
The carrying amount of goodwill was as follows (in thousands):
Carrying Amount
Balance as of January 31, 2024
$8,145 
   Acquisition of Oxeye8,055 
   Acquisition measurement period adjustment(310)
   Foreign currency translation adjustments
249 
Balance as of January 31, 2025
$16,139 
There was no goodwill impairment for any periods presented.
Intangible Assets
Intangible assets, net consisted of the following (in thousands):
January 31, 2025
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (1)
$22,913 $(10,982)$11,931 2.2
Developed technology from asset acquisitions (2)
7,660 (1,757)5,903 2.3
Total$30,573 $(12,739)$17,834 
January 31, 2024
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination$6,200 $(4,467)$1,733 0.8
Developed technology from asset acquisitions (1) (2)
914 (914)— 0.0
Total$7,114 $(5,381)$1,733 
(1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
(2) During the years ended January 31, 2025 and 2024, the Company wrote off $0.9 million and $0.4 million of fully amortized intangible assets as the technology had become obsolete, respectively.
Amortization expense was $8.1 million, $2.2 million and $2.4 million for the years ended January 31, 2025, 2024 and 2023, respectively.
As of January 31, 2025, future amortization expense related to the intangibles assets is expected to be as follows (in thousands):
Fiscal Years
2026$8,124 
20278,124 
20281,586 
Total future amortization$17,834 
v3.25.1
Team Member Benefit Plans
 12 Months Ended
Jan. 31, 2025
Retirement Benefits [Abstract]  
Team Member Benefit Plans 8. Team Member Benefit PlansThe Company contributes to defined contribution plans in a number of countries including a 401(k) savings plan for U.S. based team members and defined contribution arrangements in the United Kingdom, Australia, New Zealand and select other countries based on the legislative and tax requirements of the respective countries. Total contributions to these plans were $5.9 million, $5.1 million, and $3.9 million for the years ended January 31, 2025, 2024 and 2023, respectively
v3.25.1
Equity
 12 Months Ended
Jan. 31, 2025
Equity [Abstract]  
Equity
9. Equity
In connection with the Company’s initial public offering (the “IPO”), on October 18, 2021, the Company filed a restated certificate of incorporation that authorized the issuance of 1,500,000,000 shares of Class A common stock, 250,000,000 shares of Class B common stock, and 50,000,000 shares of preferred stock at $0.0000025 par value for each class of shares. Common stockholders are entitled to dividends when and if declared by the board of directors. No dividends have been declared to date. The holder of each share of Class A common stock is entitled to one vote and the holder of each share of Class B common stock is entitled to ten votes.
Common Stock
The Company had shares of common stock reserved for future issuance as follows (in thousands):
January 31, 2025January 31, 2024
Class A and Class B common stock
Options issued and outstanding5,896 8,503 
Shares available for issuance under Equity Incentive Plans31,852 24,868 
RSUs and PSUs issued and outstanding8,743 10,930 
Shares reserved for issuance to charitable organizations1,183 1,404 
ESPP 6,554 5,398 
Total54,228 51,103 
Equity Incentive Plans
In September 2021, in connection with the IPO, the board of directors and stockholders approved the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor to the Company’s 2015 Plan (together the “Plans”). The 2021 Plan authorizes the award of both stock options, which are intended to qualify for tax treatment under Section 422 of the Internal Revenue Code, and nonqualified stock options, as well for the award of restricted stock awards (“RSAs”), stock appreciation rights (“SARs”), restricted stock units (“RSUs”), performance stock units (“PSUs”) and stock bonus awards. Pursuant to the 2021 Plan, incentive stock options may be granted only to the Company’s team members. The Company may grant all other types of awards to its team members, directors, and consultants. The Company initially reserved 13,032,289 shares of its Class A common stock, plus any reserved shares of Class B common stock not issued or subject to outstanding grants under the 2015 Plan on the effective date of the 2021 Plan, for issuance as Class A common stock pursuant to awards granted under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan increases automatically on February 1 of each of the years from 2022 through 2031.
The awards available for grant under the above Plans for the periods presented were as follows (in thousands):
January 31, 2025January 31, 2024
Available at beginning of period 24,868 21,483 
Awards authorized7,878 7,557 
RSUs and PSUs granted(5,794)(6,258)
RSUs and PSUs canceled and forfeited4,781 1,292 
Options canceled and forfeited119 777 
Options repurchased— 17 
Available at end of period 31,852 24,868 
In the event that shares previously issued under the above Plans are reacquired by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of such stock option will be added to the number of shares then available for issuance under the 2021 Plan.
Both Plans allow the grantees to early exercise stock options.
Stock Options, RSUs and PSUs
The following table summarizes options activity under the Plans, and related information:
Number of Stock Options Outstanding (in thousands)Weighted Average Exercise PriceWeighted Average Remaining YearsAggregate Intrinsic value (in millions)
Balances at January 31, 20248,503 $13.03 5.85$499.2 
Options exercised(2,488)9.63 
Options canceled(11)17.78 
Options forfeited(108)18.01 
Balances at January 31, 2025
5,896 $14.27 5.41$344.8 
Options vested at January 31, 2025
5,292 $13.77 5.32$312.2 
Options vested and expected to vest at January 31, 2025
5,896 $14.27 5.41$344.8 
No options were granted during the years ended January 31, 2025, 2024 and 2023 and the aggregate grant-date fair value of options that vested during the years ended January 31, 2025, 2024 and 2023 was $27.6 million, $17.9 million and $31.0 million, respectively. The aggregate intrinsic value of options exercised during the years ended January 31, 2025, 2024 and 2023 was $116.2 million, $128.8 million and $123.4 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the fair value of the underlying common stock on the date of exercise. During the years ended January 31, 2025, 2024 and 2023, the Company recorded $15.0 million, $17.6 million and $23.2 million stock-based compensation expense related to options, respectively.
As of January 31, 2025, approximately $21.5 million of total unrecognized stock-based compensation cost was related to stock options granted of which $19.4 million relates to the modification of stock options previously granted to our former CEO. Total unrecognized stock-based compensation cost related to stock options is expected to be recognized over a weighted-average period of 1.0 year. The
expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
The following table summarizes the Company’s RSU activity:
Number of Shares (in thousands) (1)
Weighted-
Average
grant date
fair value
Balances at January 31, 20247,701 $47.20 
Granted5,539 54.30 
Vested(3,200)49.35 
Canceled/forfeited(1,781)49.37 
Balances at January 31, 2025
8,259 $50.64 
(1) The table above does not include 3 million RSUs granted to the Co-founder and former CEO described below.
These RSUs are grants of shares of the Company’s Class A common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two to four years ratably on a combination of bi-annual and quarterly basis. During the years ended January 31, 2025, 2024 and 2023, the Company recorded $157.2 million, $117.6 million and $61.6 million stock-based compensation expense related to RSUs, respectively.
As of January 31, 2025, approximately $394.0 million of total unrecognized compensation cost was related to RSUs granted to team members that is expected to be recognized over a weighted-average period of 2.6 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures.
PSUs
In December 2024, the Company granted 0.3 million PSUs to its CEO subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition is set to be achieved in three equal tranches in fiscal year 2026, 2027 and 2028 and the service condition on each vest date. The Company recorded $1.3 million of stock-based compensation expense related to these PSUs during the year ended January 31, 2025. As of January 31, 2025, unrecognized stock-based compensation expense related to these PSUs was $17.8 million to be recognized over a period of 3.4 years.
In June 2022, the Company granted 0.4 million PSUs to senior members of its management team subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. The number of awards granted represents 100% of the target goal; under the terms of the awards, the recipients may earn between 0% and 200% of the original grant. The performance condition was achieved in fiscal year 2025 and 0.1 million PSUs are expected to vest in fiscal year 2026, subject to continuous service through the applicable vesting dates. The Company recorded $2.3 million, $1.3 million and $1.6 million of stock-based compensation expense related to PSUs during the years ended January 31, 2025, 2024 and 2023, respectively. As of January 31, 2025, unrecognized stock-based compensation expense related to these PSUs was $0.9 million to be recognized over a period of 0.9 years.
Former CEO Restricted Stock Units (“Former CEO RSU”)
In May 2021, the Company granted 3 million RSUs tied to its Class B common stock to Sytse Sijbrandij, the Company’s co-founder and former CEO, with an estimated aggregate grant date fair value of $8.8 million. As measured from the grant date, the derived service period of the respective tranches ranges from 2 to 7 years. In December 2024, Mr. Sijbrandij resigned from his position as CEO and as a result, all unvested RSUs were forfeited, which resulted in a $3.4 million net gain of stock-based compensation expense for the year ended January 31, 2025. During the years ended January 31, 2024 and 2023, the Company recorded $1.7 million and $1.7 million, respectively, of stock-based compensation expense related to the former CEO RSU. As of January 31, 2025, there was no unrecognized stock-based compensation expense remaining related to these RSUs.
2021 Employee Stock Purchase Plan (“ESPP”)
In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members.
During the quarter ended July 31, 2024, the Company’s stock price on the purchase date, May 31, 2024, was lower than the Company’s stock price on the previously applicable offering date. As a result, the offering in effect was reset with the lower stock price becoming the new offering price and rolled over to a new 24-month offering period. The reset was treated as a modification resulting in incremental expense totaling $1.0 million, which is being recognized over the remaining requisite service period as of the date of reset.
During the quarter ended July 31, 2023, the Company’s stock price on the purchase date, May 31, 2023, was lower than the Company’s stock price on the previously applicable offering date. As a result, the offering in effect was reset with the lower stock price becoming the new offering price and rolled over to a new 24-month offering period. The reset was treated as a modification resulting in incremental expense totaling $9.4 million, which is being recognized over the remaining requisite service period as of the date of reset.
The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model:
Fiscal Year Ended January 31,
202520242023
Risk-free interest rate
4.08% - 5.25%
4.22% - 5.30%
1.62% - 4.55%
Volatility
46.03% - 60.50%
40.95% - 65.56%
44.95% - 55.19%
Expected term (in years)
0.50 - 2.00
0.50 - 2.00
0.50 - 2.00
Dividend yield—%—%—%
The Company recorded $11.8 million, $19.0 million, and $25.7 million of stock-based compensation expense related to the ESPP during the years ended January 31, 2025, 2024 and 2023, respectively. As of January 31, 2025, approximately $8.1 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.8 years.
Stock-Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
Fiscal Year Ended January 31,
202520242023
Cost of revenue$7,922 $6,400 $5,078 
Sales and marketing72,954 68,766 48,001 
Research and development58,312 50,804 36,325 
General and administrative46,711 37,079 33,163 
Total stock-based compensation expense (1)
$185,899 $163,049 $122,567 
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
The corporate income tax benefit recognized in the consolidated statements of operations for stock-based compensation expense was zero for the years ended January 31, 2025 and 2024, and $7.7 million for the year ended January 31, 2023, respectively.
Charitable Donation of Common Stock
In September 2021, the Company’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2024 and 2023, the Company’s board of directors approved the donation of $11.8 million and $10.7 million aggregate principal amount of shares of Class A common stock to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation, respectively. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur in four equal quarterly distributions.
During the years ended January 31, 2025 and 2024, the Company donated 221,195 shares and 231,408 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $11.8 million and $10.7 million was recorded in general and administrative expense in the consolidated statements of operations for the years ended January 31, 2025 and 2024, respectively.
v3.25.1
Restructuring and Other Related Charges
 12 Months Ended
Jan. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Other Related Charges
10. Restructuring and Other Related Charges
In fiscal year 2025, the Company restructured certain departments to better align functions and recognized total restructuring charges of $1.9 million. In fiscal year 2024, the Company reduced its total global headcount by approximately 7% and recognized total restructuring charges of $8.0 million.
The Company recognized severance and other termination benefit costs as follows (in thousands):
Fiscal Year Ended January 31,
2025
2024 (1)
Cost of revenue$— $463 
Research and development393 2,119 
Sales and marketing1,126 3,811 
General and administrative377 1,634 
Total$1,896 $8,027 
(1) Excludes stock-based compensation of $1.3 million for the year ended January 31, 2024.
The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands):
Balance as of January 31, 2024
$188 
Charges1,896 
    Cash payments(2,084)
Balance as of January 31, 2025
$— 
v3.25.1
Joint Venture and Equity Method Investment
 12 Months Ended
Jan. 31, 2025
Noncontrolling Interest [Abstract]  
Joint Venture and Equity Method Investment
11. Joint Venture and Equity Method Investment
Joint Venture
In February 2021, the Company along with Sequoia CBC Junyuan (Hubei) Equity Investment Partnership (Limited Partnership) and Suzhou Gaocheng Xinjian Equity Investment Fund Partnership (Limited Partnership) executed an investment agreement (the “Investment Agreement”) to establish GitLab Information Technology (Hubei) Co., LTD (“JiHu”), a legal entity in the People’s Republic of China. The Company accounted for JiHu as a variable interest entity and consolidated the entity in accordance with ASC Topic 810, Consolidation. As of January 31, 2025 and 2024, the Company retains control over JiHu with its equity stake at approximately 54% for each period presented.
Since fiscal year 2023, JiHu has maintained an employee stock option plan (“JiHu 2022 ESOP”) for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan (“JiHu 2024 ESOP”) for its employees in order to grant additional shares. The fair value of restricted stock awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method; as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP (“JiHu ESOPs”).
As a result of forfeitures triggered by the departure of certain executives from JiHu in fiscal year 2025 and fiscal year 2024, the Company reversed stock-based compensation previously recorded for such executives. There were no forfeitures in fiscal year 2023. For the years ended January 31, 2025, 2024 and 2023, the Company recorded $1.8 million stock-based compensation net expense, $1.5 million net gain and $7.8 million stock-based compensation expense, respectively.
As of January 31, 2025, approximately $7.1 million of total unrecognized compensation cost was related to the JiHu ESOPs that is expected to be recognized over 3.8 years.
Operating Leases
JiHu entered into three new operating leases during the year ended January 31, 2025 and has various non-cancelable long-term operating leases maturing by June 25, 2027 with total lease payments of $0.4 million and a total present value of lease liabilities of $0.4 million. In addition, JiHu has various other short-term leases. Lease expense associated with short-term leases was $0.1 million during the year ended January 31, 2025 and immaterial for both years ended January 31, 2024 and 2023.
The Company recognized $0.4 million, $0.6 million and $0.6 million of operating lease expense during the the years ended January 31, 2025, 2024 and 2023, respectively.
The table below presents supplemental information related to operating leases for the year ended January 31, 2025 (in thousands, except weighted-average information):
Weighted-average remaining lease term (in years)1.65
Weighted-average discount rate 3.3 %
Right-of-use assets obtained in exchange for new operating lease liabilities$324 
Cash paid for amounts included in the measurement of lease liabilities
$388 
Selected Financial Information
Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands):
Fiscal Year Ended January 31,
202520242023
Revenue$7,588 $6,451 $4,743 
Cost of revenue2,252 2,414 1,731 
Gross profit5,336 4,037 3,012 
Operating expenses:
Sales and marketing6,331 7,369 7,670 
Research and development1,841 5,338 6,818 
General and administrative4,520 1,864 10,515 
Total operating expenses12,692 14,571 25,003 
Loss from operations(7,356)(10,534)(21,991)
Interest income814 1,078 659 
Other income, net483 858 1,633 
Net loss before income taxes(6,059)(8,598)(19,699)
Provision for income taxes15 16 — 
Net loss$(6,074)$(8,614)$(19,699)
Net loss attributable to noncontrolling interest$(2,793)$(3,859)$(8,385)

January 31, 2025
January 31, 2024 (1)
Cash and cash equivalents$37,991 $43,896 
Property and equipment, net322 489 
Operating lease right-of-use assets381 405 
Other assets7,804 6,378 
Total assets$46,498 $51,168 
Total liabilities$10,278 $10,079 
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Equity Method Investment
In April 2021, the Company reorganized Meltano Inc. (“Meltano”), now operating as Arch Data, Inc. (“Arch”), which started as an internal project within the Company in July 2018, into a separate legal entity.
The Company recorded an impairment charge of $8.9 million in other income (expense), net in the consolidated statement of operations during the year ended January 31, 2024 which reduced the equity method investment value to zero as of January 31, 2024.
During the years ended January 31, 2024 and 2023, the Company recorded a loss from equity method investment of $3.8 million and $2.5 million, net of tax on the consolidated statements of operations, respectively.
v3.25.1
Income Taxes
 12 Months Ended
Jan. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes
12. Income Taxes
The components of total loss from continuing operations before income taxes are as follows (in thousands):
Fiscal Year Ended January 31,
2025
2024 (1)
2023 (1)
US$(108,336)$14,328 $(4,877)
Foreign22,543 (174,895)(170,417)
Loss before income taxes$(85,793)$(160,567)$(175,294)
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
The provision for (benefit from) income taxes consisted of the following (in thousands):
Fiscal Year Ended January 31,
202520242023
Current:
Federal and State$2,028 $(1,768)$1,432 
Foreign(68,021)257,384 1,954 
Total current$(65,993)$255,616 $3,386 
Deferred:
Federal and State$(3)$(810)$614 
Foreign(10,678)10,339 30 
Total deferred$(10,681)$9,529 $644 
Provision for (benefit from) income taxes$(76,674)$265,145 $4,030 
A reconciliation of the statutory U.S. federal income tax rate to the Company's effective tax rate is as follows:
Fiscal Year Ended January 31,
2025
2024 (1)
2023 (1)
Tax at federal statutory rate21.0 %21.0 %21.0 %
State, net of federal benefit(0.1)(0.1)(0.2)
Stock-based compensation6.9 2.4 (0.4)
Non-deductible Executive Compensation(12.0)(4.7)(1.6)
Research tax credit5.5 6.2 2.7 
Foreign rate differential(2.8)(1.8)5.5 
Change in valuation allowance(4.5)(83.3)(29.0)
Foreign derived intangible income deduction0.2 — 0.6 
Unrecognized tax benefits77.5 (105.3)(1.1)
Other(2.3)0.5 0.2 
Total89.4 %(165.1)%(2.3)%
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts for income tax purposes.
Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):
January 31,
20252024
Deferred tax assets:
Net operating loss carryforwards$92,432 $85,348 
Research tax credits14,942 14,031 
Deferred revenue12,419 6,812 
Accruals and other assets2,024 6,237 
Capitalized R&D107,035 70,921 
Intangibles98,690 110,160 
Interest expense limitation10,379 35,085 
Unrealized FX282 — 
Stock-based compensation8,829 6,679 
Gross deferred tax assets347,032 335,273 
Valuation allowance(323,710)(328,385)
Net deferred tax assets23,322 6,888 
Deferred tax liabilities:
Deferred contract acquisition costs(13,628)(7,019)
Fixed assets(92)(191)
Unrealized foreign exchange adjustments— (10,024)
Federal effects of disregarded entities(9,277)— 
Other— (23)
Net deferred tax assets (liabilities)$325 $(10,369)

The Company executed the Bilateral Advanced Pricing Agreement (“BAPA”) agreements with the United States Internal Revenue Services (“IRS”) and the Netherlands’ Dutch Tax Authority (“DTA”) on October 10, 2024, and October 22, 2024, respectively. On October 28, 2024, the Company paid $187.7 million to satisfy the tax assessment issued by the DTA, including accrued interest, which reflected the BAPA negotiations and the agreement to reduce the rate of tax on the gain from the transfer of economic IP rights. As a result of the BAPA and the DTA assessment, the 2015 through 2017 tax years are closed for GitLab B.V. Pursuant to the terms in the BAPA, the Company will file amended returns for the 2018 through 2023 fiscal years; the tax returns for the fiscal year ended January 31, 2024 were filed. All U.S. federal and state tax net operating losses (“NOLs”) and credits, as well as Netherlands NOLs, are not yet recognized due to the determination that they are not more likely than not to be realized.
As of January 31, 2025, the Company’s U.S. federal 2018 through 2024 tax years were open and subject to potential examination in one or more jurisdictions. In addition, in the United States, any net operating losses or credits that were generated in prior years but not yet fully utilized in a year that is closed under the statute of limitations may also be subject to examination. The Company’s Netherlands tax years are currently open from tax years 2018 to 2024, subject to adjustments as a result of the
recently negotiated BAPA. The Company believes that it has adequately reserved for the outcome of the BAPA. The Company regularly assesses the likelihood of adverse outcomes resulting from all existing and potential examinations to determine the adequacy of its provision for income taxes. The Company continues to monitor the progress of ongoing discussions with tax authorities and the effect, if any, of the expected expiration of the statute of limitations in various taxing jurisdictions.
As of January 31, 2025, unrecognized tax benefits approximated $25.6 million, of which $9.5 million would affect the effective tax rate if recognized. As of January 31, 2024, unrecognized tax benefits approximated $402.7 million, of which $213.7 million would affect the effective tax rate if recognized. The Company has settled and paid the BAPA tax liability with the DTA, thereby reducing the current tax liability previously classified as an unrecognized tax benefit. For unrecognized tax benefits unrelated to the BAPA, the Company is unable to reasonably estimate the timing of the remaining long-term payments or the amount by which the liability will increase or decrease.
The reconciliation of the Company's unrecognized tax benefits is as follows (in thousands):
January 31,
20252024
Beginning balance$402,728 $13,364 
Gross increases due to tax positions taken in prior periods9,785 324,364 
Gross increases due to tax position taken in current period3,510 65,001 
Gross decreases due to settlement tax payment(137,262)— 
Gross decreases due to settlements with taxing authorities(253,191)— 
Gross decreases due to lapses in applicable statutes of limitations— (1)
Ending balance$25,570 $402,728 
It is the Company's policy to classify accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. For the years ended January 31, 2025, 2024 and 2023, the Company recognized interest and penalties of $5.3 million, $56.3 million and $1.3 million, respectively; these amounts are not included in the above table.
v3.25.1
Net Income (Loss) per Share
 12 Months Ended
Jan. 31, 2025
Earnings Per Share [Abstract]  
Net Income (Loss) per Share
13. Net Income (Loss) per Share
The following table sets forth basic and diluted income (loss) per share for each of the periods presented (in thousands, except per share data):
Fiscal Year Ended January 31,
202520242023
Numerator:
Net loss attributable to GitLab$(6,326)$(425,677)$(173,407)
Denominator:
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted160,580 154,283 148,407 
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(0.04)$(2.76)$(1.17)
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
As of
January 31, 2025January 31, 2024January 31, 2023
Shares subject to outstanding common stock options5,896 8,503 12,686 
Unvested restricted stock in connection with business combination1 3 8 
Unvested early exercised stock options3 22 194 
Unvested RSUs and PSUs8,743 10,930 8,336 
Shares subject to the ESPP55 63 81 
Total 14,698 19,521 21,305 
v3.25.1
Commitments and Contingencies
 12 Months Ended
Jan. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
14. Commitments and Contingencies
Contractual Obligations and Commitments
The Company’s purchase obligations represent third-party non-cancelable hosting infrastructure agreements, subscription arrangements and other commitments used in the ordinary course of business to meet operational requirements.
Future minimum payments under the Company’s non-cancelable purchase commitments as of January 31, 2025 were as follows (in thousands):
TotalLess than 1 Year1-3 Years4-5 Years
Purchase commitments (1)
$132,709 $93,490 $38,979 $240 
(1) The table above includes $32 million of remaining non-cancelable contractual commitments as of January 31, 2025 related to one of the Company’s hosting infrastructure vendors, under which the Company committed to spend an aggregate of at least $171 million between October 2020 and September 2025.
Loss Contingencies
In accordance with ASC 450, Loss Contingencies, the Company accrues for contingencies when losses become probable and reasonably estimable. Accordingly, the Company has recorded an estimated liability related to certain labor matters regarding its use of contractors in certain foreign countries. As of January 31, 2025 and January 31, 2024, the estimated liability relating to these matters was $1.4 million and $2.2 million, respectively, is recorded in other non-current liabilities on the consolidated balance sheets.
Warranties and Indemnifications
The Company enters into service level agreements with customers which warrant defined levels of uptime and support response times and permit those customers to receive credits for prepaid amounts in the event that those performance and response levels are not met. To date, the Company has not experienced any significant failures to meet defined levels of performance and response. In connection with the service level agreements, the Company has not incurred any significant costs and has not accrued any liabilities in the consolidated financial statements.
In the ordinary course of business, the Company enters into contractual arrangements under which the Company agrees to provide indemnification of varying scope and terms to business partners and other parties with respect to certain matters, including, but not limited to, losses arising out of the breach
of such agreements, intellectual property infringement claims made by third parties, and other liabilities relating to or arising from the Company’s platform or the Company’s acts or omissions. In these circumstances, payment may be conditional on the other party making a claim pursuant to the procedures specified in the particular contract. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments.
In addition, the Company has agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines, and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person’s service as a director or officer, including any action by the Company, arising out of that person’s services as the Company’s director or officer or that person’s services provided to any other company or enterprise at the Company’s request. The Company maintains director and officer insurance coverage that may enable the Company to recover a portion of any future amounts paid.
Legal Proceedings
GitLab Securities Class Action and Shareholder Derivative Cases
On September 4, 2024, a putative class action was filed in the United States District Court for the Northern District of California, captioned Dolly v. GitLab et al., Case No. 5:24-cv-06244-EKL, naming GitLab and certain of our officers. The complaint purports to assert claims under Section 10(b) of the Securities Exchange Act of 1934 (“1934 Act”), SEC Rule 10b-5, and Section 20(a) of the 1934 Act, on behalf of persons and entities who acquired our common stock between June 5, 2023 and June 3, 2024 (the “Class Period”). Plaintiff alleges that, during the Class Period, defendants made material misrepresentations or omissions regarding the Company’s use of AI features and ability to monetize the Company’s AI capabilities that artificially inflated the Company’s stock price. Plaintiff seeks, among other things, damages in an unspecified amount, as well as fees and costs. Plaintiff amended his complaint on February 5, 2025 and March 7, 2025, and we will move to dismiss the second amended complaint in April 2025.
Two putative shareholder derivative cases have been filed containing allegations based on or similar to those in the securities class action. The cases were filed on February 14, 2025, in the United States District Court for the Northern District of California, captioned Preciado v. Sijbrandij et al., Case No. 3:25-cv-01597 (“Preciado”); and on February 19, 2025 in United States District Court for the Northern District of California, captioned Jones v. Sijbrandij et al., Case No. 3:25-cv-01735 (“Jones”). Both cases are allegedly brought on the Company’s behalf. Each of the lawsuits name the Company as a nominal defendant, and also certain of the Company’s officers and current and former members of the Company’s board of directors. The Jones complaint purports to assert claims under Section 14(a) of the Exchange Act as well as breach of fiduciary duty, while the Preciado complaint purports to assert those claims as well as unjust enrichment and related corporate torts. The complaints seek to recover unspecified damages and other relief on the Company’s behalf.
Based on the preliminary nature of the proceedings in these actions, the outcomes remain uncertain and the Company cannot estimate the potential impact, if any, on its business or financial statements at this time.
In addition to the shareholder matters described above, the Company is, and from time to time may become, involved in legal proceedings or be subject to claims arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that in the opinion of management, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, financial condition or operating results.
Defending such proceedings is costly and can impose a significant burden on management and team members. The results of any current or future litigation cannot be predicted with certainty, and regardless
of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.
v3.25.1
Subsequent Events
 12 Months Ended
Jan. 31, 2025
Subsequent Events [Abstract]  
Subsequent Events
15. Subsequent Events
On March 3, 2025, the Company announced that Ian Steward will join as Chief Revenue Officer, effective May 3, 2025. Ashley Kramer, who has been serving as Interim Chief Revenue Officer while maintaining her role as Chief Marketing and Strategy Officer, will continue in both positions until the end of the first quarter of fiscal year 2026.
v3.25.1
Schedule II: Valuation and Qualifying Accounts
 12 Months Ended
Jan. 31, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II: Valuation and Qualifying Accounts
Schedule II: Valuation and Qualifying Accounts
The table below details the activity of the deferred tax valuation allowance for the fiscal years ended January 31, 2025, 2024, and 2023:

Balance at Beginning of YearAdditionsWrite-offs or DeductionsBalance at End of Year
(in thousands)
Year ended January 31, 2025
Deferred tax valuation allowance$328,385 $— $4,675 $323,710 
Year ended January 31, 2024
Deferred tax valuation allowance$159,470 $168,915 $— $328,385 
Year ended January 31, 2023
Deferred tax valuation allowance$115,839 $43,631 $— $159,470 
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Pay vs Performance Disclosure      
Net loss attributable to GitLab $ (6,326) $ (425,677) $ (173,407)
v3.25.1
Recovery of Erroneously Awarded Compensation
 12 Months Ended
Jan. 31, 2025
Restatement Determination Date:: 2025-01-31  
Erroneously Awarded Compensation Recovery  
Restatement does not require Recovery
As disclosed in “Note 2. Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements, this Form 10-K reflects our identification and correction of certain errors in our prior year financial statements. The Compensation Committee of our Board of Directors, consisting entirely of independent directors, conducted a recovery analysis of incentive-based compensation received by our executive officers during the relevant period, as contemplated by Rule 10D-1 under the Exchange Act and in accordance with our Executive Officer Clawback Policy. Based on this analysis, no recovery of incentive-based compensation is required, as the financial statement adjustments did not impact the metrics used to determine incentive compensation during the relevant recovery period, and thus there was no erroneously awarded compensation.
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Sytse Sijbrandij [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Sytse Sijbrandij 10b5-1 Plan
On December 26, 2024, Sytse Sijbrandij, Co-Founder and Executive Chair of the Board of Directors of the Company, entered into, through Mr. Sibrandij’s revocable trust and the Sijbrandij Foundation, a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Sijbrandij Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock. The Sijbrandij Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Sijbrandij Rule 10b5-1 Plan provides for the potential sale of approximately 2,173,416 shares, which reflects the aggregate number of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock, as applicable, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Sijbrandij Rule 10b5-1 Plan, between April 15, 2025 and March 18, 2026.
The Sijbrandij Rule 10b5-1 Plan includes a representation from Mr. Sijbrandij to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Sijbrandij Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Sijbrandij Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Sijbrandij Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation.
Name Sytse Sijbrandij
Title Co-Founder and Executive Chair of the Board of Directors
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 26, 2024
Expiration Date March 18, 2026
Arrangement Duration 337 days
Aggregate Available 2,173,416
Brian Robins [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Brian Robins 10b5-1 Plan
On December 31, 2024, Brian Robins, the Company’s Chief Financial Officer, along with The Robins Family Trust, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Robins Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The Robins Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Robins Rule 10b5-1 Plan provide for the potential sale of approximately 230,000 shares, which reflects shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Robins Rule 10b5-1 Plan between April 1, 2025 and February 27, 2026.
The Robins Rule 10b5-1 Plan includes a representation from Mr. Robins and The Robins Family Trust trustee to the broker administering the plan that neither was in possession of any material nonpublic information regarding the Company or the securities subject to the Robins Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Robins Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Robins Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Robins or the trustee was unaware, or with respect to any
material nonpublic information acquired by Mr. Robins, the trustee or the Company after the date of the representation.
Name Brian Robins
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 31, 2024
Expiration Date February 27, 2026
Arrangement Duration 332 days
Aggregate Available 230,000
Sabrina Farmer [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Sabrina Farmer 10b5-1 Plan
On December 31, 2024, Sabrina Farmer, the Company’s Chief Technology Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Farmer Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from vesting and settlement of restricted stock units. The Farmer Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Farmer Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock units. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 93,175 shares, which reflects the aggregate maximum number of shares underlying Ms. Farmer’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Farmer Rule 10b5-1 Plan between April 1, 2025 and December 26, 2025.
The Farmer Rule 10b5-1 Plan includes a representation from Ms. Farmer to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Farmer Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Farmer Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Farmer Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Farmer was unaware, or with respect to any material nonpublic information acquired by Ms. Farmer or the Company after the date of the representation.
Name Sabrina Farmer
Title Chief Technology Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date December 31, 2024
Expiration Date December 26, 2025
Arrangement Duration 269 days
Aggregate Available 93,175
v3.25.1
Insider Trading Policies and Procedures
 12 Months Ended
Jan. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Jan. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
GitLab’s cybersecurity program was designed in alignment with industry standards and recognized best practices to identify, assess, and manage material risks from cybersecurity threats. Our cybersecurity program is led by our Chief Information Security Officer, who has over 25 years of experience working at SaaS and technology companies, and consists of over 120 security practitioners located around the world. Our processes assess the likelihood and impact of various threats and risks including, but not limited to, our business operations, organizational output, brand reputation, business continuity, customers and stakeholders, legal, regulatory, and financial impact. Identified risks are assessed for criticality, prioritized for remediation, and reported by GitLab's security teams to various levels of our management including integration into our enterprise risk management program, led by Internal Audit. We also make judgments based on current data, assumptions about the risk, the company’s risk tolerance, impact to confidentiality, integrity, and availability, and reasonable analysis of costs associated with mitigating or reducing the severity of the risk. Our global incident response team iteratively evaluates security events for impact, using both qualitative and quantitative factors. Security incidents that are assessed as potentially material are escalated to designated members of our management and board of directors, as applicable. Our global incident response team performs at-least annual tabletop exercises of our incident processes, including material breach, disaster recovery, and business continuity scenarios.
Our security program accounts for our significant interactions with relevant external third-parties and analyzes the potential risks introduced from doing business with them. These risks are continually assessed throughout the vendor lifecycle from onboarding to offboarding. We also engage in continuous monitoring of our cyber security risks and perform security assurance activities via independent, external third parties such as consultants, auditors, security researchers, and assessors during our robust security certification audits, penetration tests, and bug bounty programs.
As of the date of this Form 10-K, to the best of our knowledge and based on available data, we have not experienced a material cybersecurity incident that has resulted in a material adverse impact to our business or operations. However, there can be no guarantee that we will not experience such an incident in the future. See Item 1A Risk Factors of this Annual Report on Form 10-K for more information on our cybersecurity risks and product vulnerability risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Our processes assess the likelihood and impact of various threats and risks including, but not limited to, our business operations, organizational output, brand reputation, business continuity, customers and stakeholders, legal, regulatory, and financial impact. Identified risks are assessed for criticality, prioritized for remediation, and reported by GitLab's security teams to various levels of our management including integration into our enterprise risk management program, led by Internal Audit.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] Our board of directors is responsible for overseeing and advising our company so that it functions as effectively as possible.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors is responsible for overseeing and advising our company so that it functions as effectively as possible. The audit committee consists of a subset of the board of directors. The audit committee has oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements and related effects on financial and other risks, and it reports any findings and recommendations, as appropriate, to the full board of directors for consideration.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The audit committee has oversight responsibility for risks and incidents relating to cybersecurity threats, including compliance with disclosure requirements and related effects on financial and other risks, and it reports any findings and recommendations, as appropriate, to the full board of directors for consideration.
Cybersecurity Risk Role of Management [Text Block] Management is responsible for and regularly discusses identifying, assessing, and managing material cybersecurity risks on an ongoing basis through programs led by the Chief Information Security Officer, Chief Legal Officer, and the Chief Financial Officer.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Management is responsible for and regularly discusses identifying, assessing, and managing material cybersecurity risks on an ongoing basis through programs led by the Chief Information Security Officer, Chief Legal Officer, and the Chief Financial Officer.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our cybersecurity program is led by our Chief Information Security Officer, who has over 25 years of experience working at SaaS and technology companies, and consists of over 120 security practitioners located around the world.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] The audit committee performs oversight functions and meets regularly with management to review the company’s business and operations, including the oversight of risks from cybersecurity threats.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Jan. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Fiscal Year
Fiscal Year
The Company's fiscal year ends on January 31. For example, references to fiscal year 2025 and 2024 refer to the fiscal year ended January 31, 2025 and 2024, respectively.
Use of Estimates
Use of Estimates
The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, allocation of revenue to the license element in the Company's self-managed subscriptions, estimating the amortization period for capitalized costs to obtain a contract, allowance for doubtful accounts, fair value of contingent consideration, taxation of intangible property in company formation, merger, or acquisition transactions, valuation allowance for deferred income taxes, reserves for unrecognized income tax benefits, valuation of acquired intangibles assets and impairment of goodwill. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.
Principles of Consolidation
Principles of Consolidation
The consolidated financial statements include 100% of the accounts of wholly owned and majority owned subsidiaries as well as a variable interest entity for which the Company is the primary beneficiary. The ownership interest of other investors is recorded as noncontrolling interest. All intercompany accounts and transactions have been eliminated in consolidation.
Foreign Currency
Foreign Currency
The reporting currency of the Company is the U.S. dollar. The Company determines the functional currency of each foreign subsidiary and the variable interest entity in accordance with ASC 830, Foreign Currency Matters, based on the currency of the primary economic environment in which each subsidiary and the variable interest entity operate. Items included in the financial statements of such subsidiaries and the variable interest entity are measured using that functional currency.
Gains and losses that arise from foreign exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other income (expense), net on the consolidated statements of operations. For the years ended January 31, 2025, 2024 and 2023, the Company recognized foreign exchange gains (losses), net of $9.4 million, $(2.9) million and $5.1 million, respectively.
For subsidiaries and the variable interest entity where the functional currency is other than the U.S. dollar, the Company uses the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate stockholders’ equity into U.S. dollars. The Company records translation gains and losses in accumulated other comprehensive income (loss) as a component of stockholders’ equity in the consolidated balance sheets.
Cash, Cash Equivalents, and Restricted Cash
Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents as of January 31, 2025 and 2024, consists of cash held in checking and savings accounts, investments in money market accounts and certain highly-liquid investments. The Company considers all highly-liquid investments purchased with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents.
Short-Term Investments - Marketable Securities
Short-Term Investments - Marketable Securities
The Company classifies its marketable securities with stated maturities of three months and greater at the date of purchase as short-term investments due to its ability to use these securities to support the Company’s current operations.
As of January 31, 2025 and 2024, all short-term investments are classified as available-for-sale and are reported at fair value, which is based on quoted market prices for such securities, if available, or based on quoted market prices of financial instruments with similar characteristics. If the fair value of a security falls below its amortized cost, the carrying value is reduced to its fair value if management intends to sell or it is more likely than not that it will be required to sell before recovery of the amortized cost basis. If neither of these conditions are satisfied, impairment is assessed for credit losses by comparing the present value of expected cash flows with the amortized cost basis, and an allowance for credit losses is recorded for the excess of amortized cost over expected cash flows. Impairment losses not attributable to credit losses are reported as a separate component of other comprehensive loss, net of tax.
The cost of securities sold is based on the specific-identification method. Unrealized gains and losses are reported as a separate component of accumulated other comprehensive income (loss). Realized gains and losses on available-for-sale securities are recognized upon sale and are included in other income (expense), net in the consolidated statements of operations. Interest on securities classified as available-for-sale is included within interest income on our consolidated statements of operations.
Available-for-sale securities are recorded at fair value each reporting period and are adjusted for the amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are included in interest income of the consolidated statements of operations.
Accounts Receivable and Allowance for Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable, which represent trade receivables from the Company’s customers, are recorded at the invoiced amount and do not bear interest. The Company extends credit of typically 30 to 60 days to its customers in the normal course of business and does not require collateral from its customers. The allowance for doubtful accounts is the Company’s best estimate of the amount of expected credit losses in existing accounts receivable.
Concentration of Credit Risk and Significant Customers
Concentration of Credit Risk and Significant Customers
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, short-term investments, and accounts receivable. At times, cash deposits may be in excess of insured limits. The Company believes that the financial institutions or corporations that hold its cash, cash equivalents, restricted cash, and short-term investments are financially sound and, accordingly, minimal credit risk exists with respect to these
balances. The Company maintains allowances for potential credit losses on accounts receivable when deemed necessary.
The Company uses various distribution channels.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
We define fair value as the price that would be received from selling an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which to transact and the market-based risk. We apply fair value accounting for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The carrying amounts reported in the consolidated financial statements approximate the fair value for cash equivalents, restricted cash, short-term investments, accounts receivable, accounts payable and accrued liabilities due to their short-term nature. The Company also recorded acquisition related contingent considerations at fair value, as further discussed in “Note 4. Cash Equivalents and Short-Term Investments.”
The Company measures assets and liabilities at each reporting period using a fair value hierarchy which requires it to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. U.S. GAAP describes a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, to measure the fair value:
Level 1 – Inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 – Inputs are unobservable based on the Company’s own assumptions used to measure assets and liabilities at fair value. The inputs require significant management judgment or estimation.
Fair value estimates are made at a specific point in time based on relevant market information and information about the financial or nonfinancial asset or liability.
Revenue Recognition
Revenue Recognition
The Company generates revenue primarily from offering self-managed (on-premise) and SaaS subscriptions. Revenue is also generated from professional services, including consulting and training.
In accordance with ASC 606, revenue is recognized when a customer obtains control of the promised products and services. The amount of revenue recognized reflects the consideration that the Company expects to be entitled to receive in exchange for these products and services. To achieve the core principle of this standard, the Company applies the following five-step model as a framework:
1)Identify the contract with a customer. We consider the terms and conditions of our arrangements with customers to identify contracts under ASC 606. We consider that we have a contract with a customer when the contract is approved, we can identify each party's rights regarding the products and services to be transferred, we can identify the payment terms for the products and
services, we have determined the customer has the ability and intent to pay, and the contract has commercial substance. We apply judgment in determining the customer's ability and intent to pay, which is based upon factors including the customer's historical payment experience or, for new customers, credit and financial information pertaining to the customers. At contract inception, we also evaluate whether two or more contracts should be combined and accounted for as a single contract. Further, contract modifications generally qualify as a separate contract.
The typical term of a subscription contract for a self-managed or SaaS offering is one to three years. Our contracts are non-cancelable over the contract term and we act as principal in all our customer contracts. Customers have the right to terminate their contracts generally only if we breach the contract and we fail to remedy the breach in accordance with the contractual terms.
2)Identify the performance obligations in the contract. Performance obligations in our contracts are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the product or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the product or service is separately identifiable from other promises in the contract.
Our self-managed subscriptions include two performance obligations: (i) to provide access to proprietary features in our software, and (ii) to provide support and maintenance (including the combined obligation to provide software updates on a when-and-if-available basis).
Our SaaS products provide access to hosted software as well as support, which is evaluated to be a single performance obligation.
Services-related performance obligations relate to the provision of consulting and training services. These services are distinct from subscriptions and do not result in significant customization of the software.
Some of our customers have the option to purchase additional licenses or renew at a stated price. These options are evaluated on a case-by-case basis but generally do not provide a material right as they are either at the same price as the existing licenses or are within our range of standalone selling price (“SSP”) and, as such, would not result in a separate performance obligation. Where material rights are identified in our contracts, they are treated as separate performance obligations.
3)Determine the transaction price. We determine transaction price based on the consideration to which we expect to be entitled in exchange for transferring products and services to the customer.
Our contracts are non-refundable and non-cancellable. We do not offer refunds, rebates, or credits to our customers in the normal course of business.
For contracts with a one year term, we applied a practical expedient available under ASC 606 and therefore do not make an evaluation for the existence of a significant financing component. In these contracts, at contract inception, the period between when we expect to transfer a promised product or service to the customer and when the customer pays for that product or service will be one year or less. For contracts with terms of more than a year, we have applied judgment in determining that advance payments in such contracts are not collected with the primary intention of availing finance and therefore, do not represent a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). We do not offer the right of refund in our contracts.
4)Allocate the transaction price to the performance obligations in the contract. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, we allocate the transaction price for each contract to each performance obligation based on the relative SSP
for each performance obligation. We use judgment in determining the SSP for our products and services. We typically assess the SSP for our products and services on an annual basis or when facts and circumstances change. To determine SSP, we maximize the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, we utilize available information that may include other observable inputs or use the expected cost-plus margin approach to estimate the price we would charge if the products and services were sold separately. The expected cost-plus margin approach is currently used to determine SSP for each distinct performance obligation for self-managed subscriptions.
We have concluded that (i) the right to use the software and (ii) the right to receive technical support and software fixes and updates are two distinct performance obligations in our self-managed subscriptions. Since neither of these performance obligations are sold on a standalone basis, we estimate SSP for each performance obligation using a model based on the “expected cost-plus margin” approach and update the model on an annual basis or when facts and circumstances change. This model uses observable data points to develop the main inputs and assumptions, which include the estimated historical costs to develop the paid features in the software license and the estimated future costs to provide post-contract customer support.
5)Revenue is recognized when or as we satisfy a performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised products and services to a customer. We recognize revenue when we transfer control of the products and services to our customers for an amount that reflects the consideration that we expect to receive in exchange for those products and services. All revenue is generated from contracts with customers.
Subscription - self-managed and SaaS
Subscription - self-managed
The Company's self-managed subscriptions include support, maintenance, upgrades, and updates on a when-and-if-available basis. Revenue for self-managed subscriptions is recognized ratably over the contract period based on the stand-ready nature of subscription elements.
The Company offers two tiers of paid subscriptions as part of the self-managed model: Premium and Ultimate.
The typical term of a subscription contract for self-managed offerings is one to three years.
SaaS
We also offer two tiers of paid SaaS subscriptions: Premium and Ultimate. These subscriptions provide access to our latest managed version of our product hosted in a public or private cloud based on the customer’s preference. Revenue from our SaaS products (Subscription revenue - SaaS) is recognized ratably over the contract period when the performance obligation is satisfied.
The typical term of a subscription contract for SaaS offering is one to three years.
License - self-managed and other
The license component of our self-managed subscriptions reflects the revenue recognized by providing customers with rights to use proprietary software features.
Other revenue consists of professional services revenue which is derived from fixed fee and time and materials offerings, subject to customer acceptance for certain fixed fee offerings. Uncertainty exists about customer acceptance and therefore, control is presumed to transfer upon confirmation from the customer, as defined in each professional services contract. Accordingly, revenue is recognized upon
satisfaction of all requirements per the applicable contract. Revenue from professional services provided on a time and material basis is recognized over the period services are delivered.
The Company presents financial information about disaggregation of revenue in “Note 3. Revenues” of the consolidated financial statements.
Deferred Revenue and Contract Assets
Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. The portion of deferred revenue that the Company will recognize during the twelve-month period from the balance sheet date is recorded within current liabilities and the remaining portion is recorded as long-term.
The Company receives payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Customers are generally billed in advance, including some multi-year contracts, but the majority of customers in multi-year contracts specifically request to pay annually in advance. Where the value of revenue recognized exceeds the value of amounts invoiced for a contract at the end of a reporting period, the excess is reclassified from deferred revenue to contract assets until invoiced. Contract assets are included in prepaid expenses and other current assets on the consolidated balance sheets.
During the years ended January 31, 2025, 2024 and 2023, $331.8 million, $217.0 million and $145.9 million, respectively, of revenue was recognized, which was included in the corresponding deferred revenue balance at the beginning of the reporting periods presented.
Remaining Performance Obligations
As of January 31, 2025, the aggregate transaction price allocated to billed and unbilled remaining performance obligations for which revenue has not yet been recognized was approximately $945.0 million. Of this amount, the Company expects to recognize approximately 61% over the next 12 months and 87% over the next 24 months.
Deferred Contract Acquisition Costs
Sales commissions and bonuses that are recoverable and incremental costs of obtaining contracts with customers are capitalized.
Commissions and bonuses paid upon the acquisition of an initial contract are amortized over an estimated period of benefit which has been determined generally to be 3 years based on historical analysis of average customer life and useful life of our product offerings. Commissions paid for subsequent renewals are amortized over the renewal term. Amortization is recognized on a straight-line basis and included in sales and marketing expenses in the consolidated statements of operations. However, costs for commissions that are incremental to obtain a self-managed license contract are expensed immediately. The Company periodically reviews these deferred costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. The Company did not recognize any impairment of deferred contract acquisition costs during the periods presented.
Cost of Revenue
Cost of Revenue
Cost of revenue for self-managed and SaaS subscriptions consists primarily of allocated cloud-hosting costs paid to third party service providers, personnel-related costs associated with our customer
support personnel, including contractors, third-party payment processing fees, and allocated overhead. Personnel-related expenses consist of salaries, benefits, bonuses, and stock-based compensation.
Cost of self-managed license and other revenue consists primarily of contractor and personnel-related costs, including stock-based compensation expenses, associated with the professional services team and customer support team, and allocated overhead.
Research and Development
Research and Development
Costs related to research and development of the Company’s software offerings are expensed as incurred. These costs consist primarily of compensation paid to the Company's research and development personnel, including contractors.
The Company’s internal customer software development process follows an iterative process that results in more frequent software releases than do traditional sequential or waterfall development methodologies and also results in internal validation of the software releases very shortly before they are made available to customers. Therefore, to date, costs to develop software that is marketed externally have not been capitalized as the current software development process is essentially completed concurrently with the establishment of technological feasibility through internal validation of the software releases. As such, all related software development costs are expensed as incurred and included in research and development expenses in the consolidated statements of operations. To date, software development for internal use has been immaterial and no such costs have been capitalized.
Advertising Costs
Advertising Costs
Advertising costs are expensed as incurred and are included within sales and marketing expenses in the consolidated statements of operations. These include costs incurred on public relations, website design, advertising, field marketing, and market research services.
Loss Contingencies
Loss Contingencies
If an exposure to any potential claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company records a liability for the estimated loss. Significant judgment is required in both the determination of probability and the determination as to whether an exposure is reasonably estimable. If applicable, the Company records receivables for probable insurance or other third-party recoveries. Due to uncertainties related to these matters, accruals are based on the best information available at the time. As additional information becomes available, the Company reassesses the potential liability and may revise its estimates. These revisions in the estimates of the potential liabilities could have a material impact on the Company’s results of operations and financial position. Legal fees and other costs associated with such actions are expensed as incurred.
Income Taxes
Income Taxes
The Company is subject to income taxes in the United States and several foreign jurisdictions. The Company records a provision for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Under this method, the Company recognizes deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and the tax basis of assets and liabilities, as well as for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to taxable income for the years in which those tax assets and liabilities are expected to be realized or settled.
Valuation allowances are established when necessary to reduce deferred tax assets to the amounts more likely than not expected to be realized. Management applies significant judgment in assessing the positive and negative evidence available in the determination of the amount of deferred tax assets that
were more likely than not to be realized in the future. Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (for example, ordinary income or capital gain) within the carryback or carryforward periods available under the tax law. The Company regularly reviews the deferred tax assets for recoverability based on historical taxable income, projected future taxable income, the expected timing of the reversals of existing temporary differences, and tax planning strategies. The Company’s judgments regarding future profitability may change due to many factors, including future market conditions and the ability to successfully execute its business plans and/or tax planning strategies. Should there be a change in the ability to recover deferred tax assets, the tax provision would increase or decrease in the period in which the assessment is changed.
Compliance with income tax regulations requires the Company to take certain tax positions. In assessing the exposure associated with various filing positions, the Company determines whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of the available evidence indicates that it is more likely than not that the position will be sustained upon tax authority examination, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than fifty percent likely of being realized upon ultimate settlement. Interest and penalties related to unrecognized tax benefits, if any, are included within the provision for income taxes in the consolidated statement of operations.
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive Loss and Accumulated Other Comprehensive Income (Loss)
Comprehensive loss includes net loss and changes in stockholders’ equity that are excluded from net loss due to changes in the Company’s cumulative foreign currency translation account and unrealized gains or losses on short-term investments.
Net Loss per Share Attributable to Common Stockholders
Net Loss per Share Attributable to Common Stockholders
Basic net loss per share is based on the weighted-average effect of all common shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted-average shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming exercise or conversion of all potentially dilutive instruments. We exclude equity instruments from the calculation of diluted loss per share if the effect of including such instruments is anti-dilutive. Since we are in a net loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potentially dilutive securities outstanding would have been anti-dilutive.
Stock-Based Compensation
Stock-Based Compensation
The Company has granted equity classified stock-based awards to team members, members of its board of directors, and non-employee advisors. The majority of the Company's stock-based awards have been granted to team members and the service-based vesting condition for the majority of these awards is satisfied over four years.
The cost of stock-based awards granted to team members is measured at the grant date, based on the fair value of the award, and is generally recognized as expense on a straight-line basis over the requisite service period. Forfeitures are recorded as they occur. The Company has elected to use the Black-Scholes option pricing model to determine the fair value of stock options.
In May 2021, the Company granted 3 million shares of restricted stock units (“RSUs”) tied to our Class B common stock to Mr. Sijbrandij, our Co-founder and former CEO. The RSUs contain a service condition and a performance condition based on the achievement of eight separate stock price hurdles/tranches ranging from $95 to $500 per share. The fair value of the RSUs was determined utilizing a
Monte Carlo valuation model. We recognize total stock-based compensation expense over the derived service period of each tranche using the accelerated attribution method, regardless of whether the stock price hurdles are achieved. The RSUs were forfeited during the year ended January 31, 2025. Refer to “Note 9. Equity” for further discussion.
In September 2021, our board of directors and our stockholders approved the 2021 Employee Stock Purchase Plan (“ESPP”) to enable eligible team members to purchase shares of our Class A common stock with accumulated payroll deductions. We recognize stock-based expenses related to the shares to be issued under the ESPP on a straight-line basis over the offering period, using the Black-Scholes option-pricing model. We have been determining the volatility input based on the historical volatility of our peer group until such time as we established a 2-year public trading history of our own stock price. For the new offering period starting December 2023, we transitioned to using an average blend of historical volatility of our peer group and volatility of our own stock price when determining the volatility input.
Since fiscal year 2023, JiHu has maintained an employee stock option plan ("JiHu 2022 ESOP") for its employees. In June 2024, the board of directors of JiHu approved a new employee stock option plan ("JiHu 2024 ESOP") for its employees in order to grant additional shares. The fair value of Restricted Stock Awards (“RSAs”) and stock option awards is measured on the date of grant and compensation costs related to these awards are recognized on a graded attribution method as the grants include a performance condition for both the JiHu 2022 ESOP and JiHu 2024 ESOP ("JiHu ESOPs"). The Company considers the RSAs and stock option awards granted pursuant to the JiHu ESOP as potentially dilutive equity instruments that will result in dilution of the Company’s stake in JiHu upon vesting of such awards (or, in the case of option awards granted pursuant to the JiHu ESOP, upon vesting and subsequent exercise into shares of JiHu common stock). Any such dilution will be accounted for as an equity transaction. Until such awards granted pursuant to the JiHu ESOP are vested (or, in the case of option awards, vested and ultimately exercised into shares of JiHu common stock), the Company will continue to record the recognized stock-compensation expense of JiHu as part of the noncontrolling interest.
In June 2022, the Company granted 0.4 million performance stock units (“2022 PSUs”) to senior members of its management team and in December 2024, the Company granted 0.3 million performance stock units (“2024 PSUs”) to its new Chief Executive Officer (“CEO”). The 2022 and 2024 PSUs are subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. The fair value of 2022 and 2024 PSUs is measured at the market price of the Company’s Class A common stock on the date of grant and compensation costs related to awards expected to vest are recognized on a graded-vesting method over the requisite service periods. The estimate of awards expected to vest is reassessed by management at each reporting period.
Segment Reporting
Segment Reporting
The Company derives revenue globally and manages its business activities on a consolidated basis. The Company’s primary offering is GitLab, a complete DevSecOps platform delivered as a single application which is offered on both self-managed and SaaS models.
The Company operates its business as one operating and reportable segment as the Company’s chief operating decision maker (“CODM”), the Company’s CEO, reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance.
The Company’s CODM primarily uses consolidated net loss as the measure of profit or loss to facilitate analysis of the Company’s financial trends, and for internal planning and forecasting purposes. Consolidated expense information is included on the consolidated statements of operations. The measure of segment assets is reported on the consolidated balance sheet as total assets.
The Company presents financial information about geographical mix of revenue in “Note 3. Revenues” of the consolidated financial statements.
Business Combination
Business Combination
We include the results of operations of the businesses that we acquire beginning from the respective dates of acquisition. We allocate the fair value of the purchase price of our acquisitions to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill.
We amortize our acquired intangible assets with definite lives on a straight-line basis over a period of three years.
The liabilities for any contingent consideration are established at the time of the acquisition and will be evaluated at each reporting date. Any change in the fair value adjustment is recorded in general and administrative expenses.
Property and Equipment, Net
Property and Equipment, Net
Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. The Company depreciates leasehold improvements over the shorter of the remaining lease term or estimated useful life of five years, and computers over two years.
Leases
Leases
The Company determines whether an arrangement is or contains a lease at inception, based on whether there is an identified asset and whether the Company controls the use of the identified asset throughout the period of use. At the lease commencement date, the Company determines the lease classification between finance and operating and recognizes a right-of-use asset and corresponding lease liability for each lease component. A right-of-use asset represents the Company’s right to use an underlying asset and a lease liability represents the Company’s obligation to make payments during the lease term. The Company has operating leases for office premises leased by JiHu, as well as for an immaterial short-term sales office in India. The Company accounts for lease components and non-lease components separately. The Company does not recognize operating lease right-of-use assets and operating lease liabilities that arise from short-term leases (i.e., leases with a term of 12 months or less).
The lease liability is initially measured as the present value of the remaining lease payments over the lease term. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. The discount rate used to determine the present value is the Company’s incremental borrowing rate unless the interest rate implicit in the lease is readily determinable. The Company estimates its incremental borrowing rate based on the information available at lease commencement date for borrowings with a similar term. The right-of-use asset is initially measured as the present value of the lease payments adjusted for prepaid lease payments to lessors.
Lease expense is recognized on a straight-line basis over the lease term.
Impairment of Long-Lived Assets
Impairment of Long-lived Assets
We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset (including an intangible asset) may not be recoverable. An asset is considered impaired if its carrying amount exceeds the future undiscounted cash flow the asset is expected to generate. We measure recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If a long-lived asset (including an intangible asset) is considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value. We have made no material adjustments to our long-lived assets (including intangible assets) in any of the years presented.
We test our goodwill for impairment at least annually in the fourth fiscal quarter of each year, or more frequently if events or changes in circumstances indicate that this asset may be impaired. Based on an analysis of qualitative and quantitative factors, including our market capitalization, we determined there to be no impairment of goodwill in any of the periods presented.
Equity Method Investment
Equity Method Investment
The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest in the investee. The Company’s equity method investments are reported at cost and adjusted each period for its proportionate share of the investee’s income or loss. The cost on initial recognition of retained interest in a former subsidiary is based on fair value on the date of loss of control. The Company’s proportionate share of the net loss resulting from the investment is reported under loss from equity method investment, net of tax in our consolidated statements of operations. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Refer to “Note 11. Joint Venture and Equity Method Investment” for more information.
Recently Adopted Accounting Standards and Recently Issued Accounting Standards Not Yet Adopted
Recently Adopted Accounting Standards
In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (“Topic 280”): Improvements to Reportable Segment Disclosures, which requires public entities to disclose expanded information about their reportable segment(s)’ significant expenses and other segment items on an interim and annual basis. The Company adopted the ASU retrospectively on January 1, 2024 and the adoption did not have a material impact on the Company’s consolidated financial statements.
Recently Issued Accounting Standards Not Yet Adopted
In December 2023, the FASB issued ASU 2023-09, Income Taxes ("Topic 740"): Improvements to Income Tax Disclosures (“ASU 2023-09”), which requires public entities to disclose specific tax rate reconciliation categories, as well as income taxes paid disaggregated by jurisdiction, amongst other disclosure enhancements. The ASU is effective for annual periods beginning after December 15, 2024,
with early adoption permitted. The Company has not early adopted ASU 2023-09 and is currently evaluating the impact on the consolidated financial disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement: Reporting Comprehensive Income - Expense Disaggregation Disclosures (“Subtopic 220-40”): Disaggregation of Income Statement Expenses, which requires disclosure of disaggregated information about certain expense captions presented in the Consolidated Statements of Operations as well as disclosure about selling expenses. The ASU is effective for fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company has not early adopted ASU 2024-03 and is currently evaluating the impact on the consolidated financial disclosures.
v3.25.1
Accounting Policies (Tables)
 12 Months Ended
Jan. 31, 2025
Accounting Policies [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
The following tables summarize the revisions of previously-issued consolidated financial statements (in thousands):
Consolidated Balance Sheet
January 31, 2024
As Previously ReportedAdjustmentAs Revised
ASSETS
CURRENT ASSETS:
Prepaid expenses and other current assets$45,601 $3,542 $49,143 
Total current assets1,280,917 3,542 1,284,459 
TOTAL ASSETS$1,317,861 $3,542 $1,321,403 
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accrued expenses and other current liabilities$286,178 $15,084 $301,262 
Total current liabilities662,073 15,084 677,157 
TOTAL LIABILITIES699,927 15,084 715,011 
STOCKHOLDERS’ EQUITY:
Accumulated deficit(1,149,822)(11,466)(1,161,288)
Accumulated other comprehensive income2,335 63 2,398 
Total GitLab stockholders’ equity571,174 (11,403)559,771 
Noncontrolling interests46,760 (139)46,621 
TOTAL STOCKHOLDERS’ EQUITY617,934 (11,542)606,392 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$1,317,861 $3,542 $1,321,403 
Consolidated Statements of Operations and Consolidated Statements of Comprehensive Loss
Year Ended January 31, 2024
As Previously ReportedAdjustmentAs Revised
Other expense, net$(11,826)$(415)$(12,241)
Loss before income taxes and loss from equity method investment
(160,152)(415)(160,567)
Provision for income taxes264,057 1,088 265,145 
Net loss$(428,033)$(1,503)$(429,536)
Net loss attributable to GitLab(424,174)(1,503)(425,677)
Foreign currency translation adjustments$(4,122)$185 $(3,937)
Comprehensive loss attributable to GitLab$(421,134)$(1,318)$(422,452)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(2.75)$(0.01)$(2.76)

Year Ended January 31, 2023
As Previously ReportedAdjustmentAs Revised
Other income, net$21,585 $36 $21,621 
Loss before income taxes and loss from equity method investment
(175,330)36 (175,294)
Provision for income taxes2,898 1,132 4,030 
Net loss$(180,696)$(1,096)$(181,792)
Net loss attributable to GitLab(172,311)(1,096)(173,407)
Foreign currency translation adjustments$(5,874)$(237)$(6,111)
Comprehensive loss attributable to GitLab$(180,740)$(1,333)$(182,073)
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(1.16)$(0.01)$(1.17)
v3.25.1
Revenues (Tables)
 12 Months Ended
Jan. 31, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table shows the components of revenues and their respective percentages of total revenue for the periods indicated (in thousands, except percentages):
Fiscal Year Ended January 31,
202520242023
Subscription—self-managed and SaaS$675,179 89 %$506,306 87 %$369,349 87 %
Subscription—self-managed458,883 61 355,707 61 275,275 65 
SaaS216,296 28 150,599 26 94,074 22 
License—self-managed and other$84,070 11 %$73,600 13 %$54,987 13 %
License—self-managed68,366 9 63,110 11 46,046 11 
Professional services and other15,704 2 10,490 2 8,941 2 
Total revenue$759,249 100 %$579,906 100 %$424,336 100 %
Revenue by Geographic Location
The following table summarizes the Company’s total revenue by geographic location based on the region of the Company’s contracting entity, which may be different than the region of the customer (in thousands):
Fiscal Year Ended January 31,
202520242023
United States$618,658 $473,021 $352,975 
Europe122,651 93,292 61,820 
Asia Pacific17,940 13,593 9,541 
Total revenue$759,249 $579,906 $424,336 
v3.25.1
Cash Equivalents and Short-Term Investments (Tables)
 12 Months Ended
Jan. 31, 2025
Cash and Cash Equivalents [Abstract]  
Schedule of Short Term Investments
The following table summarizes the Company’s cash equivalents and short-term investments by category (in thousands):
As of January 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$97,093 $— $— $97,093 
Level 2:
Cash equivalents
    U.S. Treasury securities36,429 8 — 36,437 
Total cash equivalents (1)
133,522 8 — 133,530 
Short-term investments
    Commercial paper19,400 4 (11)19,393 
    Corporate debt securities220,326 327 (148)220,505 
    U.S. Agency securities61,020 20 (65)60,975 
 U.S. Treasury securities463,474 521 (140)463,855 
Total short-term investments764,220 872 (364)764,728 
Level 2 total800,649 880 (364)801,165 
Total cash equivalents and short-term investments$897,742 $880 $(364)$898,258 
(1) Included in “cash and cash equivalents” in our consolidated balance sheet as of January 31, 2025, in addition to cash of $94.1 million.
As of January 31, 2024
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Level 1:
Cash equivalents
    Money market funds$187,175 $— $— $187,175 
Level 2:
Cash equivalents
    U.S. Treasury securities15,909 — (2)15,907 
    Commercial paper3,962 — (1)3,961 
Total cash equivalents (1)
207,046 — (3)207,043 
Short-term investments
    Commercial paper23,229 14 (1)23,242 
    Corporate debt securities231,219 740 (250)231,709 
    U.S. Agency securities56,324 29 (136)56,217 
    U.S. Treasury securities437,369 141 (389)437,121 
Total short-term investments748,141 924 (776)748,289 
Level 2 total768,012 924 (779)768,157 
Total cash equivalents and short-term investments$955,187 $924 $(779)$955,332 
(1) Included in “cash and cash equivalents” in our consolidated balance sheet as of January 31, 2024, in addition to cash of $81.0 million.
Schedule of Unrealized Losses Cash Equivalents and Short Term Investment
The following table summarizes unrealized losses on the Company’s cash equivalents and short-term investments aggregated by category and the length of time such aggregated investments have been in a continuous unrealized loss position as of the periods presented (in thousands):
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2025
    U.S. Agency securities$48,445 $(65)$— $— $48,445 $(65)
    Commercial paper13,430 (11)— — 13,430 (11)
    Corporate debt securities72,022 (146)5,988 (2)78,010 (148)
    U.S. Treasury securities100,921 (140)— — 100,921 (140)
Total cash equivalents and short-term investments$234,818 $(362)$5,988 $(2)$240,806 $(364)
Less Than 12 Months12 Months or GreaterTotal
Carrying ValueGross Unrealized LossesCarrying ValueGross Unrealized LossesFair ValueGross Unrealized Losses
January 31, 2024
    U.S. Agency securities$35,979 $(53)$11,386 $(83)$47,365 $(136)
    Commercial paper15,462 (2)— — 15,462 (2)
    Corporate debt securities85,998 (192)15,485 (58)101,483 (250)
    U.S. Treasury securities139,567 (192)41,193 (199)180,760 (391)
Total cash equivalents and short-term investments$277,006 $(439)$68,064 $(340)$345,070 $(779)
Schedule of Short Term Investments by Contractual Maturity
The following table classifies the Company’s short-term investments by contractual maturities (in thousands):
January 31, 2025January 31, 2024
Amortized costFair ValueAmortized costFair Value
Due within 1 year$590,193 $590,832 $619,286 $618,765 
Due between 1 year to 2 years174,027 173,896 128,855 129,524 
Total$764,220 $764,728 $748,141 $748,289 
v3.25.1
Supplemental Financial Statement Information (Tables)
 12 Months Ended
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
January 31, 2025January 31, 2024
Prepaid software subscriptions$10,769 $12,835 
Prepaid income taxes 6,302 7,891 
Interest receivable5,893 4,159 
Indirect tax credit receivable (1)
3,698 3,663 
Prepaid insurance2,945 2,718 
Revenue contract asset2,432 1,910 
Other prepaid expenses2,199 1,776 
Vendor receivable1,951 2,000 
Prepaid expenses for the Company’s events1,950 9,245 
Prepaid advertising costs689 1,621 
Security and other deposits264 371 
Other current assets1,319 954 
Total prepaid expenses and other current assets$40,411 $49,143 
(1) The Company revised prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Schedule of Property, Plant and Equipment, Net
Property and equipment, net of the following (in thousands):
January 31, 2025January 31, 2024
Computer and office equipment $7,012 $9,182 
Leasehold improvements78 1,154 
7,090 10,336 
Less: Accumulated depreciation (1)
(3,077)(7,382)
Total property and equipment, net (1)
$4,013 $2,954 
(1) The amounts in the table above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying property and equipment. As of January 31, 2025 and January 31, 2024, the Company also wrote off $7.2 million and $1.1 million of fully depreciated assets as they were no longer in use, respectively.
Schedule of Other Non-Current Assets
Other non-current assets consisted of the following (in thousands):
January 31, 2025January 31, 2024
Security and other deposits$3,924 $3,495 
Deferred software implementation costs143 336 
Other non-current assets370 559 
Total other non-current assets$4,437 $4,390 
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consisted of the following (in thousands):
January 31, 2025January 31, 2024
Indirect taxes payable (1)
$18,779 $9,971 
Accrued expenses13,292 11,499 
Income taxes payable (1)
13,111 11,253 
Customer refunds payable6,268 3,019 
ESPP employee contributions2,955 2,827 
Operating lease liabilities, current275 410 
Income tax liability related to BAPA (2)
— 258,675 
Acquisition related liabilities (3)
— 3,608 
Total accrued expenses and other current liabilities$54,680 $301,262 
(1) The Company has revised prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
(2) Refer to “Note 12. Income Taxes”.
(3) Refer to “Note 4. Cash Equivalents and Short-Term Investments”.
Schedule of Accrued Compensation and Benefits
Accrued compensation and benefits consisted of the following (in thousands):
January 31, 2025January 31, 2024
Accrued commissions$16,538 $12,734 
Other accrued team member related payables15,564 13,581 
Payroll taxes payable 8,131 9,306 
Restructuring accrual and related charges (1)
— 188 
Total accrued compensation and benefits$40,233 $35,809 
(1) Refer to “Note 10. Restructuring and Other Related Charges”.
Schedule of Other Non-Current Liabilities
Other non-current liabilities consisted of the following (in thousands):
January 31, 2025January 31, 2024
Long term taxes payable$4,888 $771 
Provision towards labor matters (1)
1,380 2,197 
Operating lease liabilities, non-current117 — 
Early exercised options liability70 420 
Deferred tax liabilities, net44 10,560 
Other non-current liabilities 58 112 
Total other non-current liabilities$6,557 $14,060 
(1) Refer to “Note 14. Commitments and Contingencies”.
Schedule of Other Income (Expense), Net
Other income (expense), net consisted of the following (in thousands):
Fiscal Year Ended January 31,
202520242023
Gain from deconsolidation of Arch, formerly Meltano$— $— $17,798 
Impairment loss of equity method investment in Arch, formerly Meltano— (8,858)— 
Foreign exchange gains (losses), net9,416 (2,871)5,131 
Other expense, net(229)(512)(1,308)
Total other income (expense), net$9,187 $(12,241)$21,621 
v3.25.1
Acquisitions (Tables)
 12 Months Ended
Jan. 31, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Business Acquisitions, by Acquisition
The transaction was accounted for as a business combination. The Acquisition Date fair value of the consideration transferred consisted of the following (in thousands):
Closing cash consideration$16,737 
Cash held in escrow3,593 
Total consideration$20,330 
The following table reflects the fair values of assets acquired and liabilities assumed at the acquisition date (in thousands):
Cash and cash equivalents$120 
Developed technology16,276 
Goodwill8,055 
Prepaid expenses and other current assets121 
Accrued expenses and payroll(3,582)
Deferred tax liability (660)
Net assets acquired$20,330 
v3.25.1
Goodwill and Intangible Assets, Net (Tables)
 12 Months Ended
Jan. 31, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The carrying amount of goodwill was as follows (in thousands):
Carrying Amount
Balance as of January 31, 2024
$8,145 
   Acquisition of Oxeye8,055 
   Acquisition measurement period adjustment(310)
   Foreign currency translation adjustments
249 
Balance as of January 31, 2025
$16,139 
Schedule of Finite-Lived Intangible Assets
Intangible assets, net consisted of the following (in thousands):
January 31, 2025
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination (1)
$22,913 $(10,982)$11,931 2.2
Developed technology from asset acquisitions (2)
7,660 (1,757)5,903 2.3
Total$30,573 $(12,739)$17,834 
January 31, 2024
Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted average remaining amortization period (years)
Developed technology from business combination$6,200 $(4,467)$1,733 0.8
Developed technology from asset acquisitions (1) (2)
914 (914)— 0.0
Total$7,114 $(5,381)$1,733 
(1) The amounts in the tables above include cumulative foreign currency translation adjustments, reflecting movement in the currencies of the underlying intangibles.
(2) During the years ended January 31, 2025 and 2024, the Company wrote off $0.9 million and $0.4 million of fully amortized intangible assets as the technology had become obsolete, respectively.
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of January 31, 2025, future amortization expense related to the intangibles assets is expected to be as follows (in thousands):
Fiscal Years
2026$8,124 
20278,124 
20281,586 
Total future amortization$17,834 
v3.25.1
Equity (Tables)
 12 Months Ended
Jan. 31, 2025
Equity [Abstract]  
Schedule of Stock Reserved For Future Issuance
The Company had shares of common stock reserved for future issuance as follows (in thousands):
January 31, 2025January 31, 2024
Class A and Class B common stock
Options issued and outstanding5,896 8,503 
Shares available for issuance under Equity Incentive Plans31,852 24,868 
RSUs and PSUs issued and outstanding8,743 10,930 
Shares reserved for issuance to charitable organizations1,183 1,404 
ESPP 6,554 5,398 
Total54,228 51,103 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The awards available for grant under the above Plans for the periods presented were as follows (in thousands):
January 31, 2025January 31, 2024
Available at beginning of period 24,868 21,483 
Awards authorized7,878 7,557 
RSUs and PSUs granted(5,794)(6,258)
RSUs and PSUs canceled and forfeited4,781 1,292 
Options canceled and forfeited119 777 
Options repurchased— 17 
Available at end of period 31,852 24,868 
Share-based Payment Arrangement, Option, Activity
The following table summarizes options activity under the Plans, and related information:
Number of Stock Options Outstanding (in thousands)Weighted Average Exercise PriceWeighted Average Remaining YearsAggregate Intrinsic value (in millions)
Balances at January 31, 20248,503 $13.03 5.85$499.2 
Options exercised(2,488)9.63 
Options canceled(11)17.78 
Options forfeited(108)18.01 
Balances at January 31, 2025
5,896 $14.27 5.41$344.8 
Options vested at January 31, 2025
5,292 $13.77 5.32$312.2 
Options vested and expected to vest at January 31, 2025
5,896 $14.27 5.41$344.8 
Schedule of Restricted Stock Units Activity
The following table summarizes the Company’s RSU activity:
Number of Shares (in thousands) (1)
Weighted-
Average
grant date
fair value
Balances at January 31, 20247,701 $47.20 
Granted5,539 54.30 
Vested(3,200)49.35 
Canceled/forfeited(1,781)49.37 
Balances at January 31, 2025
8,259 $50.64 
(1) The table above does not include 3 million RSUs granted to the Co-founder and former CEO described below.
Schedule of Estimating the Fair Value of the ESPP
The following table summarizes assumptions used in estimating the fair value of the ESPP for the offering period in effect using the Black-Scholes option-pricing model:
Fiscal Year Ended January 31,
202520242023
Risk-free interest rate
4.08% - 5.25%
4.22% - 5.30%
1.62% - 4.55%
Volatility
46.03% - 60.50%
40.95% - 65.56%
44.95% - 55.19%
Expected term (in years)
0.50 - 2.00
0.50 - 2.00
0.50 - 2.00
Dividend yield—%—%—%
Schedule of Share Based Compensation Expense
The Company recognized stock-based compensation expense as follows (in thousands):
Fiscal Year Ended January 31,
202520242023
Cost of revenue$7,922 $6,400 $5,078 
Sales and marketing72,954 68,766 48,001 
Research and development58,312 50,804 36,325 
General and administrative46,711 37,079 33,163 
Total stock-based compensation expense (1)
$185,899 $163,049 $122,567 
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Restructuring and Other Related Charges (Tables)
 12 Months Ended
Jan. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges
The Company recognized severance and other termination benefit costs as follows (in thousands):
Fiscal Year Ended January 31,
2025
2024 (1)
Cost of revenue$— $463 
Research and development393 2,119 
Sales and marketing1,126 3,811 
General and administrative377 1,634 
Total$1,896 $8,027 
(1) Excludes stock-based compensation of $1.3 million for the year ended January 31, 2024.
Schedule of Restructuring Reserve by Type of Cost
The changes in liabilities resulting from the restructuring charges and related accruals were as follows (in thousands):
Balance as of January 31, 2024
$188 
Charges1,896 
    Cash payments(2,084)
Balance as of January 31, 2025
$— 
v3.25.1
Joint Venture and Equity Method Investment (Tables)
 12 Months Ended
Jan. 31, 2025
Noncontrolling Interest [Abstract]  
Schedule of Supplemental Information Related to Operating Leases
The table below presents supplemental information related to operating leases for the year ended January 31, 2025 (in thousands, except weighted-average information):
Weighted-average remaining lease term (in years)1.65
Weighted-average discount rate 3.3 %
Right-of-use assets obtained in exchange for new operating lease liabilities$324 
Cash paid for amounts included in the measurement of lease liabilities
$388 
Schedule of Variable Interest Entities
Selected financial information of JiHu, post intercompany eliminations, is as follows (in thousands):
Fiscal Year Ended January 31,
202520242023
Revenue$7,588 $6,451 $4,743 
Cost of revenue2,252 2,414 1,731 
Gross profit5,336 4,037 3,012 
Operating expenses:
Sales and marketing6,331 7,369 7,670 
Research and development1,841 5,338 6,818 
General and administrative4,520 1,864 10,515 
Total operating expenses12,692 14,571 25,003 
Loss from operations(7,356)(10,534)(21,991)
Interest income814 1,078 659 
Other income, net483 858 1,633 
Net loss before income taxes(6,059)(8,598)(19,699)
Provision for income taxes15 16 — 
Net loss$(6,074)$(8,614)$(19,699)
Net loss attributable to noncontrolling interest$(2,793)$(3,859)$(8,385)

January 31, 2025
January 31, 2024 (1)
Cash and cash equivalents$37,991 $43,896 
Property and equipment, net322 489 
Operating lease right-of-use assets381 405 
Other assets7,804 6,378 
Total assets$46,498 $51,168 
Total liabilities$10,278 $10,079 
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
v3.25.1
Income Taxes (Tables)
 12 Months Ended
Jan. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The components of total loss from continuing operations before income taxes are as follows (in thousands):
Fiscal Year Ended January 31,
2025
2024 (1)
2023 (1)
US$(108,336)$14,328 $(4,877)
Foreign22,543 (174,895)(170,417)
Loss before income taxes$(85,793)$(160,567)$(175,294)
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Schedule of Components of Income Tax Expense (Benefit)
The provision for (benefit from) income taxes consisted of the following (in thousands):
Fiscal Year Ended January 31,
202520242023
Current:
Federal and State$2,028 $(1,768)$1,432 
Foreign(68,021)257,384 1,954 
Total current$(65,993)$255,616 $3,386 
Deferred:
Federal and State$(3)$(810)$614 
Foreign(10,678)10,339 30 
Total deferred$(10,681)$9,529 $644 
Provision for (benefit from) income taxes$(76,674)$265,145 $4,030 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the statutory U.S. federal income tax rate to the Company's effective tax rate is as follows:
Fiscal Year Ended January 31,
2025
2024 (1)
2023 (1)
Tax at federal statutory rate21.0 %21.0 %21.0 %
State, net of federal benefit(0.1)(0.1)(0.2)
Stock-based compensation6.9 2.4 (0.4)
Non-deductible Executive Compensation(12.0)(4.7)(1.6)
Research tax credit5.5 6.2 2.7 
Foreign rate differential(2.8)(1.8)5.5 
Change in valuation allowance(4.5)(83.3)(29.0)
Foreign derived intangible income deduction0.2 — 0.6 
Unrecognized tax benefits77.5 (105.3)(1.1)
Other(2.3)0.5 0.2 
Total89.4 %(165.1)%(2.3)%
(1) The Company revised the prior-period balances. Refer to “Note 2. Basis of Presentation and Summary of Significant Accounting Policies”.
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company's deferred tax assets and liabilities are as follows (in thousands):
January 31,
20252024
Deferred tax assets:
Net operating loss carryforwards$92,432 $85,348 
Research tax credits14,942 14,031 
Deferred revenue12,419 6,812 
Accruals and other assets2,024 6,237 
Capitalized R&D107,035 70,921 
Intangibles98,690 110,160 
Interest expense limitation10,379 35,085 
Unrealized FX282 — 
Stock-based compensation8,829 6,679 
Gross deferred tax assets347,032 335,273 
Valuation allowance(323,710)(328,385)
Net deferred tax assets23,322 6,888 
Deferred tax liabilities:
Deferred contract acquisition costs(13,628)(7,019)
Fixed assets(92)(191)
Unrealized foreign exchange adjustments— (10,024)
Federal effects of disregarded entities(9,277)— 
Other— (23)
Net deferred tax assets (liabilities)$325 $(10,369)
Schedule of Unrecognized Tax Benefits Roll Forward
The reconciliation of the Company's unrecognized tax benefits is as follows (in thousands):
January 31,
20252024
Beginning balance$402,728 $13,364 
Gross increases due to tax positions taken in prior periods9,785 324,364 
Gross increases due to tax position taken in current period3,510 65,001 
Gross decreases due to settlement tax payment(137,262)— 
Gross decreases due to settlements with taxing authorities(253,191)— 
Gross decreases due to lapses in applicable statutes of limitations— (1)
Ending balance$25,570 $402,728 
v3.25.1
Net Income (Loss) per Share (Tables)
 12 Months Ended
Jan. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth basic and diluted income (loss) per share for each of the periods presented (in thousands, except per share data):
Fiscal Year Ended January 31,
202520242023
Numerator:
Net loss attributable to GitLab$(6,326)$(425,677)$(173,407)
Denominator:
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted160,580 154,283 148,407 
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic and diluted$(0.04)$(2.76)$(1.17)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in thousands):
As of
January 31, 2025January 31, 2024January 31, 2023
Shares subject to outstanding common stock options5,896 8,503 12,686 
Unvested restricted stock in connection with business combination1 3 8 
Unvested early exercised stock options3 22 194 
Unvested RSUs and PSUs8,743 10,930 8,336 
Shares subject to the ESPP55 63 81 
Total 14,698 19,521 21,305 
v3.25.1
Commitments and Contingencies (Tables)
 12 Months Ended
Jan. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Contractual Obligation, Fiscal Year Maturity
Future minimum payments under the Company’s non-cancelable purchase commitments as of January 31, 2025 were as follows (in thousands):
TotalLess than 1 Year1-3 Years4-5 Years
Purchase commitments (1)
$132,709 $93,490 $38,979 $240 
(1) The table above includes $32 million of remaining non-cancelable contractual commitments as of January 31, 2025 related to one of the Company’s hosting infrastructure vendors, under which the Company committed to spend an aggregate of at least $171 million between October 2020 and September 2025.
v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)
$ / shares in Units, shares in Millions
 1 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Jun. 30, 2022
shares
May 31, 2021
target
$ / shares
shares
Jan. 31, 2025
USD ($)
period
obligation
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Significant Accounting Policies [Line Items]            
Foreign exchange gains (losses), net       $ 9,416,000 $ (2,871,000) $ 5,131,000
Foreign currency translation adjustments       (11,934,000) (3,937,000) (6,111,000)
Restricted cash           2,500,000
Allowance for doubtful accounts       $ 991,000 673,000  
Number of performance obligations | obligation       2    
Deferred revenue recognized       $ 331,800,000 217,000,000 145,900,000
Remaining performance obligation       $ 945,000,000    
Deferred contract acquisition cost, term       3 years    
Advertising costs       $ 34,500,000 $ 32,500,000 $ 27,300,000
Award vesting period (in years)       4 years    
Number of operating segments | period       1    
Number of reporting segments | period       1    
Intangible assets acquired, useful life (in years)       3 years    
Goodwill impairment       $ 0    
Internal-use software            
Significant Accounting Policies [Line Items]            
Property and equipment, useful life (in years)       5 years    
Computers            
Significant Accounting Policies [Line Items]            
Property and equipment, useful life (in years)       2 years    
PSUs            
Significant Accounting Policies [Line Items]            
RSUs granted in period (in shares) | shares   0.4        
Board of Directors Chairman | RSUs            
Significant Accounting Policies [Line Items]            
RSUs granted in period (in shares) | shares     3.0      
Number of threshold stock price targets | target     8      
Chief Executive Officer | PSUs            
Significant Accounting Policies [Line Items]            
RSUs granted in period (in shares) | shares 0.3          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-02-01            
Significant Accounting Policies [Line Items]            
Remaining performance obligation, next twelve months (as a percent)       61.00%    
Remaining performance obligation, next twenty four months (as a percent)       87.00%    
Minimum            
Significant Accounting Policies [Line Items]            
Subscription contract term (in years)       1 year    
Minimum | Board of Directors Chairman | RSUs            
Significant Accounting Policies [Line Items]            
Threshold stock price target (in dollars per share) | $ / shares     $ 95      
Maximum            
Significant Accounting Policies [Line Items]            
Subscription contract term (in years)       3 years    
Maximum | Board of Directors Chairman | RSUs            
Significant Accounting Policies [Line Items]            
Threshold stock price target (in dollars per share) | $ / shares     $ 500      
Distribution Channel One | Accounts Receivable | Credit Concentration Risk            
Significant Accounting Policies [Line Items]            
Concentration risk, percentage       11.00% 12.00%  
Distribution Channel Two | Accounts Receivable | Credit Concentration Risk            
Significant Accounting Policies [Line Items]            
Concentration risk, percentage       12.00% 13.00%  
v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies - Revision of Previously Issued Consolidated Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Jan. 31, 2022
Consolidated Balance Sheet        
Prepaid expenses and other current assets [1] $ 40,411 $ 49,143    
Total current assets [1] 1,336,317 1,284,459    
TOTAL ASSETS [1] 1,399,263 1,321,403    
Accrued expenses and other current liabilities [1] 54,680 301,262    
Total current liabilities [1] 545,031 677,157    
TOTAL LIABILITIES [1] 577,957 715,011    
Accumulated deficit [1] (1,167,614) (1,161,288)    
Accumulated other comprehensive income (loss) [1] (8,508) 2,398    
Total GitLab stockholders’ equity [1] 775,909 559,771    
Noncontrolling interests [1] 45,397 46,621    
TOTAL STOCKHOLDERS’ EQUITY 821,306 [1] 606,392 [1] $ 814,501 $ 790,378
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY [1] 1,399,263 1,321,403    
Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income        
Other income, net 9,187 (12,241) 21,621  
Loss before income taxes and loss from equity method investment (85,793) (160,567) (175,294)  
Provision for (benefit from) income taxes (76,674) 265,145 4,030  
Net loss (9,119) (429,536) (181,792)  
Net loss attributable to GitLab (6,326) (425,677) (173,407)  
Foreign currency translation adjustments (11,934) (3,937) (6,111)  
Comprehensive loss attributable to GitLab $ (17,232) $ (422,452) $ (182,073)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share) $ (0.04) $ (2.76) $ (1.17)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share) $ (0.04) $ (2.76) $ (1.17)  
As Previously Reported        
Consolidated Balance Sheet        
Prepaid expenses and other current assets   $ 45,601    
Total current assets   1,280,917    
TOTAL ASSETS   1,317,861    
Accrued expenses and other current liabilities   286,178    
Total current liabilities   662,073    
TOTAL LIABILITIES   699,927    
Accumulated deficit   (1,149,822)    
Accumulated other comprehensive income (loss)   2,335    
Total GitLab stockholders’ equity   571,174    
Noncontrolling interests   46,760    
TOTAL STOCKHOLDERS’ EQUITY   617,934    
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   1,317,861    
Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income        
Other income, net   (11,826) $ 21,585  
Loss before income taxes and loss from equity method investment   (160,152) (175,330)  
Provision for (benefit from) income taxes   264,057 2,898  
Net loss   (428,033) (180,696)  
Net loss attributable to GitLab   (424,174) (172,311)  
Foreign currency translation adjustments   (4,122) (5,874)  
Comprehensive loss attributable to GitLab   $ (421,134) $ (180,740)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)   $ (2.75) $ (1.16)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)   $ (2.75) $ (1.16)  
Adjustment        
Consolidated Balance Sheet        
Prepaid expenses and other current assets   $ 3,542    
Total current assets   3,542    
TOTAL ASSETS   3,542    
Accrued expenses and other current liabilities   15,084    
Total current liabilities   15,084    
TOTAL LIABILITIES   15,084    
Accumulated deficit   (11,466)    
Accumulated other comprehensive income (loss)   63    
Total GitLab stockholders’ equity   (11,403)    
Noncontrolling interests   (139)    
TOTAL STOCKHOLDERS’ EQUITY   (11,542)    
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   3,542    
Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income        
Other income, net   (415) $ 36  
Loss before income taxes and loss from equity method investment   (415) 36  
Provision for (benefit from) income taxes   1,088 1,132  
Net loss   (1,503) (1,096)  
Net loss attributable to GitLab   (1,503) (1,096)  
Foreign currency translation adjustments   185 (237)  
Comprehensive loss attributable to GitLab   $ (1,318) $ (1,333)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share)   $ (0.01) $ (0.01)  
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share)   $ (0.01) $ (0.01)  
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Revenues - Disaggregation of Revenue by Product and Service (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Disaggregation of Revenue [Line Items]      
Total revenue $ 759,249 $ 579,906 $ 424,336
Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 100.00% 100.00% 100.00%
Subscription—self-managed and SaaS      
Disaggregation of Revenue [Line Items]      
Total revenue $ 675,179 $ 506,306 $ 369,349
Subscription—self-managed and SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 89.00% 87.00% 87.00%
Subscription—self-managed      
Disaggregation of Revenue [Line Items]      
Total revenue $ 458,883 $ 355,707 $ 275,275
Subscription—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 61.00% 61.00% 65.00%
SaaS      
Disaggregation of Revenue [Line Items]      
Total revenue $ 216,296 $ 150,599 $ 94,074
SaaS | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 28.00% 26.00% 22.00%
License—self-managed and other      
Disaggregation of Revenue [Line Items]      
Total revenue $ 84,070 $ 73,600 $ 54,987
License—self-managed and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 11.00% 13.00% 13.00%
License—self-managed      
Disaggregation of Revenue [Line Items]      
Total revenue $ 68,366 $ 63,110 $ 46,046
License—self-managed | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 9.00% 11.00% 11.00%
Professional services and other      
Disaggregation of Revenue [Line Items]      
Total revenue $ 15,704 $ 10,490 $ 8,941
Professional services and other | Revenue from Contract with Customer, Product and Service Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 2.00% 2.00% 2.00%
v3.25.1
Revenues - Disaggregation of Revenue by Geographic Region (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Disaggregation of Revenue [Line Items]      
Total revenue $ 759,249 $ 579,906 $ 424,336
United States      
Disaggregation of Revenue [Line Items]      
Total revenue 618,658 473,021 352,975
Europe      
Disaggregation of Revenue [Line Items]      
Total revenue 122,651 93,292 61,820
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Total revenue $ 17,940 $ 13,593 $ 9,541
v3.25.1
Revenues - Narrative (Details)
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk, percentage 82.00% 82.00% 83.00%
v3.25.1
Cash Equivalents and Short-Term Investments - Schedule of Cash and Short Term Investments (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Debt Securities, Available-for-sale [Line Items]      
Cash and cash equivalents $ 227,649 [1] $ 287,996 [1] $ 295,402
Cash equivalents and short-term investments, amortized cost 897,742 955,187  
Cash equivalents and short-term investments, gross unrealized gains 880 924  
Cash equivalents and short-term investments, gross unrealized losses (364) (779)  
Cash equivalents and short-term investments, fair value 898,258 955,332  
Level 2      
Debt Securities, Available-for-sale [Line Items]      
Cash equivalents and short-term investments, amortized cost 800,649 768,012  
Cash equivalents and short-term investments, gross unrealized gains 880 924  
Cash equivalents and short-term investments, gross unrealized losses (364) (779)  
Cash equivalents and short-term investments, fair value 801,165 768,157  
Cash and Cash Equivalents | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Cash and cash equivalents 133,522 207,046  
Cash equivalents, gross unrealized gains 8 0  
Cash equivalents, gross unrealized losses 0 (3)  
Cash equivalents, fair value 133,530 207,043  
Short-Term Investments | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost 764,220 748,141  
Short-term investments, gross unrealized gains 872 924  
Short-term investments, gross unrealized losses (364) (776)  
Short-term investments, fair value 764,728 748,289  
Money market funds | Cash and Cash Equivalents | Level 1      
Debt Securities, Available-for-sale [Line Items]      
Cash and cash equivalents 97,093 187,175  
Cash equivalents, fair value 97,093 187,175  
U.S. Treasury securities | Cash and Cash Equivalents | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Cash and cash equivalents 36,429 15,909  
Cash equivalents, gross unrealized gains 8 0  
Cash equivalents, gross unrealized losses 0 (2)  
Cash equivalents, fair value 36,437 15,907  
U.S. Treasury securities | Short-Term Investments | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost 463,474 437,369  
Short-term investments, gross unrealized gains 521 141  
Short-term investments, gross unrealized losses (140) (389)  
Short-term investments, fair value 463,855 437,121  
Commercial paper | Cash and Cash Equivalents | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Cash and cash equivalents   3,962  
Cash equivalents, gross unrealized gains   0  
Cash equivalents, gross unrealized losses   (1)  
Cash equivalents, fair value   3,961  
Commercial paper | Short-Term Investments | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost 19,400 23,229  
Short-term investments, gross unrealized gains 4 14  
Short-term investments, gross unrealized losses (11) (1)  
Short-term investments, fair value 19,393 23,242  
Corporate debt securities | Short-Term Investments | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost 220,326 231,219  
Short-term investments, gross unrealized gains 327 740  
Short-term investments, gross unrealized losses (148) (250)  
Short-term investments, fair value 220,505 231,709  
U.S. Agency securities | Short-Term Investments | Level 2      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost 61,020 56,324  
Short-term investments, gross unrealized gains 20 29  
Short-term investments, gross unrealized losses (65) (136)  
Short-term investments, fair value 60,975 56,217  
Cash | Cash and Cash Equivalents      
Debt Securities, Available-for-sale [Line Items]      
Short-term investments, amortized cost $ 94,100 $ 81,000  
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Interest and investment income $ 47,700 $ 39,100 $ 14,500
Net amortization of premiums or discounts on short-term investments 16,746 20,349 6,077
Contingent consideration liability, current 0 3,608  
Change in fair value of acquisition related contingent consideration 3,750 0 (1,722)
Accretion expense 100 200 300
Opstrace Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Change in fair value of acquisition related contingent consideration 3,800 0 $ (1,700)
Payment for contingent consideration liability, operating activities 7,500    
Fair Value, Inputs, Level 3 | Opstrace Inc.      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Contingent payment $ 0 $ 3,600  
v3.25.1
Cash Equivalents and Short-Term Investments - Schedule of Unrealized Losses Cash Equivalents and Short Term Investment (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value $ 234,818 $ 277,006
Less than 12 months, gross unrealized losses (362) (439)
12 months or greater, carrying value 5,988 68,064
12 months or greater, gross unrealized losses (2) (340)
Fair Value 240,806 345,070
Gross Unrealized Losses (364) (779)
U.S. Agency securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 48,445 35,979
Less than 12 months, gross unrealized losses (65) (53)
12 months or greater, carrying value 0 11,386
12 months or greater, gross unrealized losses 0 (83)
Fair Value 48,445 47,365
Gross Unrealized Losses (65) (136)
Commercial paper    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 13,430 15,462
Less than 12 months, gross unrealized losses (11) (2)
12 months or greater, carrying value 0 0
12 months or greater, gross unrealized losses 0 0
Fair Value 13,430 15,462
Gross Unrealized Losses (11) (2)
Corporate debt securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 72,022 85,998
Less than 12 months, gross unrealized losses (146) (192)
12 months or greater, carrying value 5,988 15,485
12 months or greater, gross unrealized losses (2) (58)
Fair Value 78,010 101,483
Gross Unrealized Losses (148) (250)
U.S. Treasury securities    
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]    
Less than 12 months, carrying value 100,921 139,567
Less than 12 months, gross unrealized losses (140) (192)
12 months or greater, carrying value 0 41,193
12 months or greater, gross unrealized losses 0 (199)
Fair Value 100,921 180,760
Gross Unrealized Losses $ (140) $ (391)
v3.25.1
Cash Equivalents and Short-Term Investments - Schedule of Short Term Investments by Contractual Maturity (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Amortized cost    
Due within 1 year $ 590,193 $ 619,286
Due between 1 year to 2 years 174,027 128,855
Total 764,220 748,141
Fair Value    
Due within 1 year 590,832 618,765
Due between 1 year to 2 years 173,896 129,524
Total $ 764,728 $ 748,289
v3.25.1
Supplemental Financial Statement Information - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid software subscriptions $ 10,769 $ 12,835
Prepaid income taxes 6,302 7,891
Interest receivable 5,893 4,159
Indirect tax credit receivable 3,698 3,663
Prepaid insurance 2,945 2,718
Revenue contract asset 2,432 1,910
Other prepaid expenses 2,199 1,776
Vendor receivable 1,951 2,000
Prepaid expenses for the Company’s events 1,950 9,245
Prepaid advertising costs 689 1,621
Security and other deposits 264 371
Other current assets 1,319 954
Total prepaid expenses and other current assets [1] $ 40,411 $ 49,143
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Supplemental Financial Statement Information - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 7,090 $ 10,336  
Less: Accumulated depreciation (3,077) (7,382)  
Property and equipment, net [1] 4,013 2,954  
Write off of fully depreciated assets 7,200 1,100  
Depreciation expense 2,900 4,400 $ 3,200
Computer and office equipment      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross 7,012 9,182  
Leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property and equipment, gross $ 78 $ 1,154  
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Supplemental Financial Statement Information - Schedule of Other Long-Term Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Security and other deposits $ 3,924 $ 3,495
Deferred software implementation costs 143 336
Other non-current assets 370 559
Total other non-current assets [1] $ 4,437 $ 4,390
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Supplemental Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Indirect taxes payable $ 18,779 $ 9,971
Accrued expenses 13,292 11,499
Income taxes payable 13,111 11,253
Customer refunds payable 6,268 3,019
ESPP employee contributions $ 2,955 $ 2,827
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total accrued expenses and other current liabilities Total accrued expenses and other current liabilities
Operating lease liabilities, current $ 275 $ 410
Income tax liability related to BAPA 0 258,675
Acquisition related liabilities 0 3,608
Total accrued expenses and other current liabilities [1] $ 54,680 $ 301,262
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Supplemental Financial Statement Information - Schedule of Accrued Compensation and Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2024
Jan. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued commissions $ 12,734 $ 16,538
Other accrued team member related payables 13,581 15,564
Payroll taxes payable $ 9,306 8,131
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] Employee-related Liabilities, Current  
Restructuring accrual and related charges $ 188 0
Total accrued compensation and benefits $ 35,809 $ 40,233
v3.25.1
Supplemental Financial Statement Information - Other Non-Current Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Long term taxes payable $ 4,888 $ 771
Provision towards labor matters $ 1,380 2,197
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Total other non-current liabilities  
Operating lease liabilities, non-current $ 117 0
Early exercised options liability 70 420
Deferred tax liabilities, net 44 10,560
Other non-current liabilities 58 112
Total other non-current liabilities [1] $ 6,557 $ 14,060
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Supplemental Financial Statement Information - Other Income, Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Gain from deconsolidation of Arch, formerly Meltano $ 0 $ 0 $ 17,798
Impairment of equity method investment 0 (8,858) 0
Foreign exchange gains (losses), net 9,416 (2,871) 5,131
Other expense, net (229) (512) (1,308)
Total other income (expense), net $ 9,187 $ (12,241) $ 21,621
v3.25.1
Acquisitions - Schedule of Total Consideration Transferred (Details) - Oxeye Security Limited - USD ($)
$ in Thousands
 12 Months Ended
Mar. 20, 2024
Jan. 31, 2025
Business Acquisition [Line Items]    
Closing cash consideration $ 16,737  
Cash held in escrow 3,593  
Total consideration $ 20,330 $ 20,300
v3.25.1
Acquisitions - Narrative (Details)
$ in Thousands
 12 Months Ended
May 23, 2024
USD ($)
Mar. 20, 2024
USD ($)
co-founder
tranche
Jan. 31, 2023
USD ($)
Dec. 03, 2021
USD ($)
Jan. 31, 2025
USD ($)
co-founder
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Business Acquisition [Line Items]              
Intangible assets acquired, useful life (in years)         3 years    
Number of co-founders | co-founder   2     2    
Change in fair value of acquisition related contingent consideration         $ 3,750 $ 0 $ (1,722)
Adjustment to goodwill         (310)    
Rezilion Asset Acquisition              
Business Acquisition [Line Items]              
Asset acquisition, consideration transferred $ 7,300            
Finite-lived intangible assets acquired 7,700            
Acquisition related costs $ 400            
Intangible assets acquired, useful life (in years) 3 years            
Opstrace Inc.              
Business Acquisition [Line Items]              
Total consideration       $ 13,500      
Cash held in escrow     $ 2,500        
Post-closing indemnification term     18 months       18 months
Change in fair value of acquisition related contingent consideration         3,800 $ 0 $ (1,700)
Oxeye Security Limited              
Business Acquisition [Line Items]              
Total consideration   $ 20,330     20,300    
Cash held in escrow   $ 3,593          
Post-closing indemnification term   15 months          
Acquisition related costs         1,200    
Closing cash consideration   $ 16,737          
Adjustment to goodwill         (300)    
Adjustment to deferred tax liabilities         300    
Oxeye Security Limited | Developed Technology              
Business Acquisition [Line Items]              
Intangible assets acquired, useful life (in years)   3 years          
Oxeye Security Limited | Founder Holdback              
Business Acquisition [Line Items]              
Contingent payment   $ 3,200          
Number of contingent payment tranches | tranche   3          
Closing cash consideration         1,100    
Change in fair value of acquisition related contingent consideration         $ 1,100    
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche One              
Business Acquisition [Line Items]              
Contingent payment, time-based vesting, percentage   33.30%          
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche Three              
Business Acquisition [Line Items]              
Contingent payment, time-based vesting, percentage   33.30%          
Oxeye Security Limited | Founder Holdback | Business Combination, Contingent Consideration, Tranche Two              
Business Acquisition [Line Items]              
Contingent payment, time-based vesting, percentage   33.30%          
v3.25.1
Acquisitions - Schedule of Preliminary Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Mar. 20, 2024
Jan. 31, 2024
Business Acquisition [Line Items]      
Goodwill [1] $ 16,139   $ 8,145
Oxeye Security Limited      
Business Acquisition [Line Items]      
Cash and cash equivalents   $ 120  
Goodwill   8,055  
Prepaid expenses and other current assets   121  
Accrued expenses and payroll   (3,582)  
Deferred tax liability   (660)  
Net assets acquired   20,330  
Oxeye Security Limited | Developed Technology      
Business Acquisition [Line Items]      
Developed technology   $ 16,276  
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Goodwill and Intangible Assets, Net - Rollforward of Goodwill (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
USD ($)
Goodwill [Roll Forward]  
Goodwill, beginning balance $ 8,145 [1]
Acquisition of Oxeye 8,055
Acquisition measurement period adjustment (310)
Foreign currency translation adjustments 249
Goodwill, ending balance $ 16,139 [1]
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Goodwill and Intangible Assets, Net - Narrative (Details) - USD ($)
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]      
Goodwill impairment $ 0    
Intangible assets, fully amortized 900,000 $ 400,000  
Amortization of intangible assets $ 8,126,000 $ 2,167,000 $ 2,362,000
v3.25.1
Goodwill and Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 30,573 $ 7,114
Accumulated Amortization (12,739) (5,381)
Total future amortization 17,834 1,733
Developed technology from business combination    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 22,913 6,200
Accumulated Amortization (10,982) (4,467)
Total future amortization $ 11,931 $ 1,733
Weighted average remaining amortization period (years) 2 years 2 months 12 days 9 months 18 days
Developed technology from asset acquisitions    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 7,660 $ 914
Accumulated Amortization (1,757) (914)
Total future amortization $ 5,903 $ 0
Weighted average remaining amortization period (years) 2 years 3 months 18 days 0 years
v3.25.1
Goodwill and Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]    
2026 $ 8,124  
2027 8,124  
2028 1,586  
Total future amortization $ 17,834 $ 1,733
v3.25.1
Team Member Benefit Plans (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Retirement Benefits [Abstract]      
Defined contribution plan, contribution amount $ 5.9 $ 5.1 $ 3.9
v3.25.1
Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2024
tranche
shares
Jun. 30, 2022
shares
May 31, 2021
USD ($)
shares
Jul. 31, 2024
USD ($)
Jul. 31, 2023
USD ($)
Jan. 31, 2026
shares
Jan. 31, 2025
USD ($)
vote
distribution
$ / shares
shares
Jan. 31, 2024
USD ($)
$ / shares
shares
Jan. 31, 2023
USD ($)
shares
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Oct. 18, 2021
$ / shares
shares
Sep. 30, 2021
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Preferred stock, shares authorized (in shares) | shares             50,000,000 50,000,000       50,000,000  
Preferred stock, par value (in USD per share) | $ / shares             $ 0.0000025 $ 0.0000025       $ 0.0000025  
Options granted (in shares) | shares             0 0 0        
Aggregate intrinsic value, options vested             $ 27,600 $ 17,900 $ 31,000        
Intrinsic value of options exercised             116,200 128,800 123,400        
Total stock-based compensation expense (gain)             185,899 163,049 122,567        
Compensation expense not yet recognized             $ 21,500            
Award vesting period (in years)             4 years            
Grant date fair value of RSUs granted     $ 8,800                    
Offering period       24 months 24 months                
Tax benefit for stock-based compensation expense             $ 0 0 7,700        
Number of distributions, donation | distribution             4            
Charitable donation of common stock             $ 11,827 10,700          
Shares subject to outstanding common stock options                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             $ 15,000 17,600 23,200        
Period for recognition (in years)             1 year            
Shares subject to outstanding common stock options | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Compensation expense not yet recognized, modification             $ 19,400            
RSUs                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             $ 157,200 117,600 61,600        
Period for recognition (in years)             2 years 7 months 6 days            
Compensation expense not yet recognized             $ 394,000            
RSUs | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             (3,400) 1,700 1,700        
Compensation expense not yet recognized             $ 0            
RSUs | Minimum | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Service period (in years)     2 years                    
RSUs | Maximum | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Service period (in years)     7 years                    
PSUs                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
RSUs granted in period (in shares) | shares   400,000                      
PSUs | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
RSUs granted in period (in shares) | shares 300,000                        
2021 Equity Incentive Plan | RSUs | Minimum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting period (in years)             2 years            
2021 Equity Incentive Plan | RSUs | Maximum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting period (in years)             4 years            
2024 Plan | PSUs                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             $ 1,300            
Period for recognition (in years)             3 years 4 months 24 days            
Compensation expense not yet recognized             $ 17,800            
RSUs granted in period (in shares) | shares 300,000                        
Award vesting percentage 100.00%                        
Number of payment tranches | tranche 3                        
2024 Plan | PSUs | Minimum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting percentage 0.00%                        
2024 Plan | PSUs | Maximum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting percentage 200.00%                        
2022 Plan | PSUs                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             $ 2,300 1,300 1,600        
Period for recognition (in years)             10 months 24 days            
Compensation expense not yet recognized             $ 900            
RSUs granted in period (in shares) | shares   400,000                      
Award vesting percentage   100.00%                      
2022 Plan | PSUs | Forecast                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Awards vested in period (in shares) | shares           100,000              
2022 Plan | PSUs | Minimum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting percentage   0.00%                      
2022 Plan | PSUs | Maximum                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Award vesting percentage   200.00%                      
2021 Employee Stock Purchase Plan | ESPP                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Total stock-based compensation expense (gain)             $ 11,800 $ 19,000 $ 25,700        
Period for recognition (in years)             1 year 9 months 18 days            
Compensation expense not yet recognized             $ 8,100            
Plan modification, cost not yet recognized       $ 1,000 $ 9,400                
Class A Common Stock                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Common stock, shares authorized (in shares) | shares             1,500,000,000 1,500,000,000       1,500,000,000  
Common stock, par value (in USD per share) | $ / shares             $ 0.0000025 $ 0.0000025       $ 0.0000025  
Voting rights, vote per share | vote             1            
Common stock reserved for future issuance (in shares) | shares                         1,635,545
Aggregate principal amount, donation                   $ 11,800 $ 10,700    
Charitable donation of common stock (in shares) | shares             221,195 231,408          
Charitable donation of common stock             $ 11,800 $ 10,700          
Class A Common Stock | 2021 Equity Incentive Plan                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Common stock reserved for future issuance (in shares) | shares                         13,032,289
Class B Common Stock                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Common stock, shares authorized (in shares) | shares             250,000,000 250,000,000       250,000,000  
Common stock, par value (in USD per share) | $ / shares             $ 0.0000025 $ 0.0000025       $ 0.0000025  
Voting rights, vote per share | vote             10            
Class B Common Stock | RSUs | Chief Executive Officer                          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
RSUs granted in period (in shares) | shares     3,000,000                    
v3.25.1
Equity - Schedule of Stock Reserved For Future Issuance (Details) - shares
shares in Thousands
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Class of Stock [Line Items]      
Options issued and outstanding (in shares) 5,896 8,503  
Shares available for issuance under Equity Incentive Plans (in shares) 31,852 24,868 21,483
Class A and Class B common stock      
Class of Stock [Line Items]      
Options issued and outstanding (in shares) 5,896 8,503  
Shares available for issuance under Equity Incentive Plans (in shares) 31,852 24,868  
Shares reserved for issuance to charitable organizations (in shares) 1,183 1,404  
Common stock reserved for future issuance (in shares) 54,228 51,103  
RSUs and PSUs | Class A and Class B common stock      
Class of Stock [Line Items]      
Share-based compensation awards other than options (in shares) 8,743 10,930  
ESPP | Class A and Class B common stock      
Class of Stock [Line Items]      
Share-based compensation awards other than options (in shares) 6,554 5,398  
v3.25.1
Equity - Awards Available for Grant (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]    
Balance, beginning of period (in shares) 24,868 21,483
Awards authorized (in shares) 7,878 7,557
Options cancelled and forfeited (in shares) 119 777
Options repurchased (in shares) 0 17
Balance, end of period (in shares) 31,852 24,868
RSUs and PSUs    
Share-based Compensation Arrangement by Share-based Payment Award, Awards Available For Grant [Roll Forward]    
RSUs and PSUs granted (in shares) (5,794) (6,258)
RSUs and PSUs cancelled and forfeited (in shares) 4,781 1,292
v3.25.1
Equity - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Number of Stock Options Outstanding (in thousands)    
Balance, beginning of period (in shares) 8,503  
Options exercised (in shares) (2,488)  
Options cancelled (in shares) (11)  
Options forfeited (in shares) (108)  
Balance, end of period (in shares) 5,896 8,503
Options vested (in shares) 5,292  
Options expected to vest (in shares) 5,896  
Weighted Average Exercise Price    
Balance, beginning of period (in USD per share) $ 13.03  
Options exercised (in USD per share) 9.63  
Options cancelled (in USD per share) 17.78  
Options forfeited (in USD per share) 18.01  
Balance, end of period (in USD per share) 14.27 $ 13.03
Options vested (in USD per share) 13.77  
Options expected to vest (in USD per share) $ 14.27  
Weighted Average Remaining Years    
Outstanding (in years) 5 years 4 months 28 days 5 years 10 months 6 days
Options vested (in years) 5 years 3 months 25 days  
Options expected to vest (in years) 5 years 4 months 28 days  
Aggregate Intrinsic value (in millions)    
Outstanding value $ 344.8 $ 499.2
Options vested 312.2  
Options expected to vest $ 344.8  
v3.25.1
Equity - Schedule of Restricted Stock Units Activity (Details) - RSUs
shares in Thousands
 12 Months Ended
Jan. 31, 2025
$ / shares
shares
Number of Shares  
Balance, beginning of period (in shares) 7,701
Granted (in shares) 5,539
Vested (in shares) (3,200)
Canceled/forfeited (in shares) (1,781)
Balance, ending of period (in shares) 8,259
Weighted- Average grant date fair value  
Balance, beginning of period (in USD per share) | $ / shares $ 47.20
Granted (in USD per share) | $ / shares 54.30
Vested (in USD per share) | $ / shares 49.35
Canceled/forfeited (in USD per share) | $ / shares 49.37
Balance, ending of period (in USD per share) | $ / shares $ 50.64
Chief Executive Officer  
Number of Shares  
Granted (in shares) 3,000
v3.25.1
Equity - Schedule of Weighted Average Fair Value Assumptions (Details) - ESPP
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Risk-free interest rate, minimum (as a percent) 4.08% 4.22% 1.62%
Risk-free interest rate, maximum (as a percent) 5.25% 5.30% 4.55%
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility (as a percent) 46.03% 40.95% 44.95%
Expected term (in years) 6 months 6 months 6 months
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility (as a percent) 60.50% 65.56% 55.19%
Expected term (in years) 2 years 2 years 2 years
v3.25.1
Equity - Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense (gain) $ 185,899 $ 163,049 $ 122,567
Cost of revenue      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense (gain) 7,922 6,400 5,078
Sales and marketing      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense (gain) 72,954 68,766 48,001
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense (gain) 58,312 50,804 36,325
General and administrative      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total stock-based compensation expense (gain) $ 46,711 $ 37,079 $ 33,163
v3.25.1
Restructuring and Other Related Charges - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Restructuring Cost and Reserve [Line Items]    
Positions eliminated, percent   7.00%
Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges $ 1,896 $ 8,027
v3.25.1
Restructuring and Other Related Charges - Schedule of Restructuring Costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges $ 1,896 $ 8,027
One-time Termination Benefits    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges   1,300
Cost of revenue | Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges 0 463
Research and development | Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges 393 2,119
Sales and marketing | Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges 1,126 3,811
General and administrative | Employee Severance    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges $ 377 $ 1,634
v3.25.1
Restructuring and Other Related Charges - Restructuring Accrual (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Restructuring Reserve [Roll Forward]    
Beginning balance $ 188  
Ending balance 0 $ 188
Employee Severance    
Restructuring Reserve [Roll Forward]    
Beginning balance 188  
Charges 1,896 8,027
Cash payments (2,084)  
Ending balance $ 0 $ 188
v3.25.1
Joint Venture and Equity Method Investment - Narrative (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
USD ($)
lease
Jan. 31, 2024
USD ($)
Jan. 31, 2023
USD ($)
Noncontrolling Interest [Line Items]      
Total stock-based compensation expense (gain) $ 185,899 $ 163,049 $ 122,567
Operating lease, number of leases entered into | lease 3    
Operating lease, total lease payments $ 400    
Operating lease liabilities 400    
Short-term lease, cost 100 0 0
Operating lease expense 400 600 600
Impairment of equity method investment 0 8,858 0
Equity method investment   0  
Loss from equity method investment, net of tax 0 3,824 2,468
Arch (Meltano Inc.)      
Noncontrolling Interest [Line Items]      
Loss from equity method investment, net of tax   3,800 2,500
GitLab Information Technology (Hubei) Co., LTD ("JiHu")      
Noncontrolling Interest [Line Items]      
Total stock-based compensation expense (gain) 1,800 $ (1,500) $ 7,800
Compensation expense not yet recognized $ 7,100    
Period for recognition (in years) 3 years 9 months 18 days    
GitLab Information Technology (Hubei) Co., LTD ("JiHu")      
Noncontrolling Interest [Line Items]      
Ownership percentage 54.00% 54.00%  
v3.25.1
Joint Venture and Equity Method Investment - Supplemental Information Related to Operating Leases (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
USD ($)
Leases [Abstract]  
Weighted-average remaining lease term (in years) 1 year 7 months 24 days
Weighted-average discount rate 3.30%
Right-of-use assets obtained in exchange for new operating lease liabilities $ 324
Cash paid for amounts included in the measurement of lease liabilities $ 388
v3.25.1
Joint Venture and Equity Method Investment - Schedule of Intercompany Eliminations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Noncontrolling Interest [Line Items]      
Revenue $ 759,249 $ 579,906 $ 424,336
Cost of revenue 85,140 59,708 51,680
Gross profit 674,109 520,198 372,656
Sales and marketing 384,295 356,393 309,992
Research and development 239,652 200,840 156,143
Total operating expenses 816,824 707,638 584,067
Loss from operations (142,715) (187,440) (211,411)
Interest income 47,735 39,114 14,496
Other income, net 9,187 (12,241) 21,621
Provision for (benefit from) income taxes (76,674) 265,145 4,030
Net loss (9,119) (429,536) (181,792)
Net loss attributable to noncontrolling interest (2,793) (3,859) (8,385)
Cash and cash equivalents 227,649 [1] 287,996 [1] 295,402
Property and equipment, net [1] 4,013 2,954  
Operating lease right-of-use assets 381 [1] 405  
TOTAL ASSETS [1] 1,399,263 1,321,403  
Total liabilities [1] 577,957 715,011  
Variable Interest Entity, Primary Beneficiary      
Noncontrolling Interest [Line Items]      
Revenue 7,588 6,451 4,743
Cost of revenue 2,252 2,414 1,731
Gross profit 5,336 4,037 3,012
Sales and marketing 6,331 7,369 7,670
Research and development 1,841 5,338 6,818
General and administrative 4,520 1,864 10,515
Total operating expenses 12,692 14,571 25,003
Loss from operations (7,356) (10,534) (21,991)
Interest income 814 1,078 659
Other income, net 483 858 1,633
Net loss before income taxes (6,059) (8,598) (19,699)
Provision for (benefit from) income taxes 15 16 0
Net loss (6,074) (8,614) (19,699)
Net loss attributable to noncontrolling interest (2,793) (3,859) $ (8,385)
Cash and cash equivalents 37,991 43,896  
Property and equipment, net 322 489  
Operating lease right-of-use assets 381 405  
Other assets 7,804 6,378  
TOTAL ASSETS 46,498 51,168  
Total liabilities $ 10,278 $ 10,079  
[1]
(1) As of January 31, 2025 and January 31, 2024, the consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.5 million and $51.2 million, respectively, and liabilities of $10.3 million and $10.1 million respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.
v3.25.1
Income Taxes - Components of Total Income (Loss) From Continuing Operations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Income Tax Disclosure [Abstract]      
US $ (108,336) $ 14,328 $ (4,877)
Foreign 22,543 (174,895) (170,417)
Loss before income taxes $ (85,793) $ (160,567) $ (175,294)
v3.25.1
Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Current:      
Federal and State $ 2,028 $ (1,768) $ 1,432
Foreign (68,021) 257,384 1,954
Total current (65,993) 255,616 3,386
Deferred:      
Federal and State (3) (810) 614
Foreign (10,678) 10,339 30
Total deferred (10,681) 9,529 644
Provision for (benefit from) income taxes $ (76,674) $ 265,145 $ 4,030
v3.25.1
Income Taxes - Effective Income Tax Rate Reconciliation (Details)
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Tax at federal statutory rate 21.00% 21.00% 21.00%
State, net of federal benefit (0.10%) (0.10%) (0.20%)
Stock-based compensation 6.90% 2.40% (0.40%)
Non-deductible Executive Compensation (12.00%) (4.70%) (1.60%)
Research tax credit 5.50% 6.20% 2.70%
Foreign rate differential (2.80%) (1.80%) 5.50%
Change in valuation allowance (4.50%) (83.30%) (29.00%)
Foreign derived intangible income deduction 0.20% 0.00% 0.60%
Unrecognized tax benefits 77.50% (105.30%) (1.10%)
Other (2.30%) 0.50% 0.20%
Total 89.40% (165.10%) (2.30%)
v3.25.1
Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2025
Jan. 31, 2024
Deferred tax assets:    
Net operating loss carryforwards $ 92,432 $ 85,348
Research tax credits 14,942 14,031
Deferred revenue 12,419 6,812
Accruals and other assets 2,024 6,237
Capitalized R&D 107,035 70,921
Intangibles 98,690 110,160
Interest expense limitation 10,379 35,085
Unrealized FX 282 0
Stock-based compensation 8,829 6,679
Gross deferred tax assets 347,032 335,273
Valuation allowance (323,710) (328,385)
Net deferred tax assets 23,322 6,888
Deferred tax liabilities:    
Deferred contract acquisition costs (13,628) (7,019)
Fixed assets (92) (191)
Unrealized foreign exchange adjustments 0 (10,024)
Federal effects of disregarded entities (9,277) 0
Other 0 (23)
Net deferred tax assets (liabilities) $ 325  
Net deferred tax assets (liabilities)   $ (10,369)
v3.25.1
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Oct. 28, 2024
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Income Tax Examination [Line Items]        
Unrecognized tax benefits   $ 25,570 $ 402,728 $ 13,364
Unrecognized tax benefits that would effect tax rate   9,500 213,700  
Interest and penalties recognized   $ 5,300 $ 56,300 $ 1,300
Dutch Tax Authority        
Income Tax Examination [Line Items]        
Income taxes paid $ 187,700      
v3.25.1
Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Unrecognized Tax Benefits [Roll Forward]    
Beginning balance $ 402,728 $ 13,364
Gross increases due to tax positions taken in prior periods 9,785 324,364
Gross increases due to tax position taken in current period 3,510 65,001
Gross decreases due to settlement tax payment (137,262) 0
Gross decreases due to settlements with taxing authorities (253,191) 0
Gross decreases due to lapses in applicable statutes of limitations 0 (1)
Ending balance $ 25,570 $ 402,728
v3.25.1
Net Income (Loss) per Share - Schedule of Earning Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Numerator:      
Net loss attributable to GitLab $ (6,326) $ (425,677) $ (173,407)
Denominator:      
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in shares) 160,580 154,283 148,407
Weighted-average shares used to compute net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in shares) 160,580 154,283 148,407
Net loss per share attributable to GitLab Class A and Class B common stockholders, basic (in USD per share) $ (0.04) $ (2.76) $ (1.17)
Net loss per share attributable to GitLab Class A and Class B common stockholders, diluted (in USD per share) $ (0.04) $ (2.76) $ (1.17)
v3.25.1
Net Income (Loss) per Share - Schedule of Potentially Dilutive Securities (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 14,698 19,521 21,305
Shares subject to outstanding common stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 5,896 8,503 12,686
Unvested restricted stock in connection with business combination      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 1 3 8
Unvested early exercised stock options      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 3 22 194
Unvested RSUs and PSUs      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 8,743 10,930 8,336
Shares subject to the ESPP      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities (in shares) 55 63 81
v3.25.1
Commitments and Contingencies - Hosting Infrastructure Commitments (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
USD ($)
vendor
Other Commitments [Line Items]  
Purchase obligation, total $ 132,709
Less than 1 Year 93,490
1-3 Years 38,979
4-5 Years $ 240
Number of hosting infrastructure vendors with purchase obligations | vendor 1
Hosting Infrastructure Commitments  
Other Commitments [Line Items]  
Purchase obligation, total $ 32,000
Minimum service commitment $ 171,000
v3.25.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
Jan. 31, 2025
Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]    
Estimate of possible loss $ 1.4 $ 2.2
v3.25.1
Schedule II: Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Beginning Balance $ 328,385 $ 159,470 $ 115,839
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 0 168,915 43,631
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction (4,675) 0 0
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount, Ending Balance $ 323,710 $ 328,385 $ 159,470